Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AC008695.1		ENSG00000273217			5	131425891-131796983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A549: 6.9;HL-60: 1.3;HMC-1: 2.7;U-937: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 11.1"									"HPA037982, HPA037983"	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "																		4.0	2.5	3.6	2.4	4.3	3.8	2.9	3.4	4.1	2.7	2.7	3.8	2.1	2.4	3.5	2.4	2.5	2.5	2.4	2.6	2.5	2.5	2.5	2.5	2.6	3.5	5.8	2.6	4.0	2.5	2.4	6.1	4.5	3.5	2.5	2.4	1.4	2.5	2.4	4.2	2.5	2.5	3.0	3.3	2.5	2.5	4.2	5.2	2.4	2.5	1.1	2.4	3.0	4.0	2.0	0.3	2.3	0.9	2.4	11.1	2.8	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	1.3	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	1.6	0.0	0.6	0.9	2.3	3.3	0.4	5.7	1.4	3.6	3.8	0.3	2.0	11.1	5.0	0.6	2.4	0.9	0.0	2.8	2.8	3.6	4.3	3.4	4.1	2.5	2.5	5.8	2.6	3.5	5.2
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA065236: "	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favourable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.4	7.9	15.6	12.9	12.8	16.2	11.7	15.3	19.5	20.7	16.5	12.4	7.9	19.7	4.5	20.9	5.5	11.7	10.5	19.6	7.9	4.9	19.6	12.4	13.2	15.2	20.8	17.5	12.7	10.8	21.4	13.4	15.9	8.8	6.9	20.8	7.5	6.9	12.4	14.5	12.7	9.1	9.8	11.7	15.6	18.0	4.6	13.4	9.9	8.7	8.7	5.6	11.6	10.8	15.8	10.3	14.5	13.7	19.3	24.5	20.1	11.7	15.2	9.8	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favourable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	15.9	11.5	2.7	12.7	10.0	11.4	16.4	8.3	10.1	8.7	5.8	10.5	11.3	21.4	12.6	5.8	13.2	13.8	9.4	2.6	15.8	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	28.9	4.9	6.9	7.4	7.9	10.5	3.1	19.9	22.4	7.4	4.0	12.5	17.7	0.1	10.4	4.7	16.0	10.8	7.5	11.4	16.6	11.4	14.7	6.1	7.8	10.9	3.8	18.0	16.0	7.3	11.2	15.8	16.0	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;MOLT-4: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA052367: , HPA063993: "	"unprognostic (5.19e-3)"	"prognostic favourable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favourable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.7	1.4	7.9	1.5	1.9	1.5	1.2	2.7	1.6	17.2	1.6	1.4	3.3	1.2	0.4	0.5	31.6	0.7	1.8	0.7	1.7	15.1	16.7	18.9	2.5	2.8	1.3	1.4	2.7	1.6	20.8	0.6	2.4	30.0	21.7	6.8	1.7	18.6	0.3	3.9	14.4	0.8	0.9	1.7	0.4	1.4	4.6	3.9	9.2	4.3	0.8	1.7	0.3	1.4	4.4	4.8	14.6	1.0	8.5	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227737-57273468	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"naive B-cell: 20.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011138, HPA073477"	Approved		Uncertain	"Mitotic spindle,Centrosome"			28000	"Mitotic spindle, Centrosome"		"HPA011138: AB_1844959, HPA073477: "	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favourable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	18.3	14.0	20.9	15.3	17.9	13.7	22.5	25.2	23.7	18.5	15.7	12.8	16.8	12.6	19.2	14.5	21.0	16.0	13.2	23.7	15.8	15.4	17.0	14.3	15.3	24.3	15.4	18.8	24.0	38.2	28.4	20.4	14.1	18.8	15.7	14.4	11.0	18.0	22.2	40.5	19.9	14.5	20.5	16.7	15.0	16.3	10.5	15.7	20.9	20.0	15.2	18.9	17.7	20.8	20.7	12.0	2.5	3.9	4.7	3.5	1.7	14.6	6.4	6.3	22.8	10.8	15.2	13.2	7.8	4.8	7.9	9.0	7.4	8.8	23.8	3.2	12.0	2.9	16.7	13.4	13.5	17.9	7.5	13.4	10.2	7.8	11.7	29.8	9.9	11.2	12.3	10.0	10.9	12.5	4.5	15.0	8.8	5.0	23.5	7.3	9.8	11.0	0.8	25.5	12.7	13.8	8.3	6.3	13.5	10.7	16.0	10.2	7.8	19.4	11.8	13.0	9.2	18.9	15.0	13.8	20.2	16.7	14.1	14.4	8.4	1.6	3.9	2.5	2.6	3.0	3.5	11.3	2.8	2.4	7.2	20.7	2.6	1.9	1.0	4.7	2.5	12.0	1.1	1.7	20.9	17.9	25.2	23.7	15.8	15.4	15.4	18.8	18.8	15.7
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Group enriched"	"Detected in some"	8	"RPTEC TERT1: 16.0;SK-BR-3: 8.9;T-47d: 9.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA036510: AB_10672357, HPA045484: "	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	16.0	0.0	0.0	0.0	0.0	8.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ARL3	ARFL3	ENSG00000138175	"ADP ribosylation factor like GTPase 3"	P36405	10	102673731-102714407	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036292, HPA063596"	Approved		Supported	Nucleoplasm,Centrosome			17000	Centrosome	Nucleoplasm	"HPA036292: AB_10673618, HPA063596: "	"unprognostic (1.36e-1)"	"unprognostic (2.89e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.99e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (1.71e-6)"	"unprognostic (5.62e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-1)"	8.8	13.8	24.8	6.6	29.4	2.9	11.4	24.1	32.9	14.1	8.9	9.6	8.2	6.8	17.1	16.7	10.2	23.0	8.3	29.9	19.9	21.4	22.7	8.1	9.6	5.5	20.2	16.0	25.2	9.9	18.9	21.0	7.7	17.6	12.1	7.7	21.5	8.8	14.5	7.9	7.9	6.4	13.4	14.2	5.3	9.0	13.6	9.3	4.1	17.3	5.5	7.2	16.0	13.8	5.0	7.8	14.9	8.1	4.5	11.1	5.8	8.5	14.8	20.4	14.9	9.5	14.2	3.6	6.8	10.4	8.3	9.1	5.1	4.4	3.6	6.6	11.0	6.4	7.7	9.1	10.4	9.3	8.0	5.8	10.6	4.8	10.3	2.7	5.8	7.2	7.7	11.5	6.8	9.5	2.6	3.6	13.8	8.8	5.4	4.3	7.8	5.9	4.6	15.1	3.1	11.0	4.6	7.2	15.7	5.2	1.1	8.0	27.2	2.7	5.4	5.7	8.0	11.5	9.3	2.6	5.1	6.6	15.0	8.0	4.9	2.3	8.1	2.7	4.5	6.5	11.1	5.0	7.8	6.5	7.8	3.5	4.8	5.7	14.9	4.5	5.5	5.7	5.2	5.8	24.8	29.4	24.1	25.6	19.9	21.4	20.2	16.0	17.6	9.3
BCAS2	"DAM1, Snt309, SPF27"	ENSG00000116752	"BCAS2, pre-mRNA processing factor"	O75934	1	114567557-114581639	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067881	Supported		Supported	"Nuclear speckles,Centrosome"				"Nuclear speckles, Centrosome"		"HPA067881: "	"unprognostic (6.93e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (8.23e-7)"	"unprognostic (1.16e-1)"	"unprognostic (8.51e-3)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (4.27e-4)"	"prognostic favourable (6.49e-4)"	"unprognostic (2.25e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (1.87e-1)"	23.2	28.0	36.7	17.6	34.1	43.0	25.0	30.4	40.6	21.3	19.7	16.5	17.3	16.7	22.9	33.2	26.0	16.6	20.7	24.5	31.6	41.8	28.7	32.9	17.5	22.4	37.0	28.8	26.8	18.2	22.9	32.5	17.4	39.0	24.1	21.0	13.9	19.5	26.7	38.4	19.0	19.0	20.1	26.9	20.8	18.3	21.2	24.6	20.0	27.8	24.5	22.1	31.1	19.5	30.4	24.8	30.9	22.6	35.4	40.1	32.9	18.9	6.9	14.4	13.6	7.7	9.0	21.6	14.3	11.0	19.0	19.6	9.7	7.8	16.9	19.8	9.2	9.3	16.7	14.1	26.5	15.2	15.0	8.8	13.8	14.0	13.9	22.2	9.6	8.1	15.5	19.6	24.3	12.4	16.9	12.7	15.6	116.3	19.8	16.6	24.9	15.8	14.2	25.4	11.8	13.3	16.6	18.8	12.5	17.8	13.8	21.9	12.2	17.6	10.8	11.6	15.5	23.3	26.8	13.8	14.2	27.3	22.7	18.6	43.9	21.6	18.5	30.9	29.3	21.9	40.1	30.4	36.7	35.7	19.4	26.7	38.2	37.2	17.6	35.4	22.6	24.8	35.8	32.9	36.7	34.1	30.4	40.6	31.6	41.8	37.0	28.8	39.0	24.6
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427297-66493529	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.5;BEWO: 4.8;RPTEC TERT1: 8.4;U-87 MG: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053851: "	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	1.2	1.2	2.9	1.1	2.5	2.9	1.2	6.9	9.6	1.2	0.7	0.1	0.0	0.6	1.2	1.9	1.8	1.9	1.4	3.0	4.6	4.1	0.9	1.1	1.4	0.9	2.3	3.2	1.4	1.9	0.1	0.4	4.5	11.6	1.0	0.9	5.0	1.9	0.4	3.6	3.2	0.8	0.8	1.7	1.2	1.2	3.1	0.2	0.0	1.9	3.1	0.9	1.0	1.0	0.3	2.4	5.2	0.5	0.4	0.2	0.1	0.8	0.9	1.0	9.5	0.3	0.1	4.8	0.3	0.0	0.1	0.1	0.0	1.0	0.1	0.5	0.3	0.2	0.1	0.1	0.3	0.0	0.6	0.0	0.2	0.7	0.7	0.1	0.0	0.7	1.9	0.6	0.3	0.0	0.1	0.3	0.2	0.5	0.0	0.4	0.3	0.5	0.1	0.2	0.5	8.4	0.6	0.1	0.2	0.2	0.2	1.4	0.2	0.1	0.3	0.4	2.6	0.1	0.4	0.5	0.1	0.1	5.5	0.2	1.3	0.4	0.5	1.9	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	5.2	0.4	0.2	2.4	0.1	0.1	2.9	2.5	6.9	9.6	4.6	4.1	2.3	3.2	11.6	0.2
BORCS6	"C17orf59, FLJ20014"	ENSG00000196544	"BLOC-1 related complex subunit 6"	Q96GS4	17	8188333-8190907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045415, HPA060791"	Uncertain		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA045415: AB_10964575, HPA060791: "	"unprognostic (2.11e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.84e-2)"	"unprognostic (9.91e-3)"	"unprognostic (7.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.60e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.10e-2)"	3.1	4.5	3.5	3.8	3.4	2.8	2.6	3.2	3.9	2.3	4.4			6.3	3.7	2.9	5.5	2.3	1.6	4.4	3.4	2.6	3.9	3.7	3.7	4.8	3.7		2.3	8.4	4.7	2.1	3.0		2.9	1.9		4.3	4.3	11.5	6.2	5.5	2.1	2.8	6.8	3.9	2.1			2.7		3.7	3.3	2.9	13.4	11.3	27.0	12.0	14.5	17.4	10.5	4.7	5.4	1.9	3.9	4.0	3.0	7.6	3.5	3.8	3.3	3.6	3.0	3.3	4.2	7.7	2.7	6.8	2.9	3.9	1.1	12.7	11.9	3.3	5.3	4.7	4.6	1.9	7.2	3.1	4.2	3.0	3.4	5.2	3.5	9.0	2.0	5.2	6.4	5.5	1.3	6.3	7.8	2.4	6.4	4.5	2.7	2.3	5.2	3.6	2.7	2.9	4.0	3.0	4.3	2.1	1.8	3.4	3.6	13.8	6.1	2.0	3.0	6.9	2.5	21.4	10.1	27.0	16.2	10.3	13.1	12.8	13.7	17.4	11.3	13.4	13.2	14.6	9.5	14.5	12.0	9.9	12.4	10.5										
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.7;hTCEpi: 28.8;T-47d: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA049367: "	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.0	4.0	0.1	1.6	1.8	2.0	5.0	1.5	1.9	4.7	1.3	3.1	11.3	0.1	17.1	1.1	17.4	0.7	33.7	2.7	0.0	2.7	0.0	1.8	0.3	5.1	0.3	0.0	4.5	28.8	4.5	19.8	15.3	0.0	0.0	0.1	10.1	0.0	18.4	1.1	11.6	0.5	0.0	1.0	0.0	13.7	3.8	1.0	6.1	3.1	3.1	30.0	5.1	15.6	3.0	7.9	1.3	4.3	4.2	3.0	13.2	0.0	4.3	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347751-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 26.0;U-138 MG: 11.6;U-2 OS: 6.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"			"Golgi apparatus, Centrosome"		"HPA061290: "	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	5.5	2.1	2.1	1.9	5.2	0.6	5.6	4.4	4.9	9.5	4.9	1.1	1.3	3.4	10.9	6.9	6.8	4.9	9.3	8.5	2.0	1.8	1.3	1.0	5.0	1.1	1.4	3.0	2.9	0.9	0.6	1.2	2.4	1.0	7.7	3.4	14.3	3.4	9.6	4.8	3.0	4.6	6.4	1.3	1.7	4.3	5.8	1.5	0.0	4.3	12.1	1.3	6.0	5.8	0.6	0.4	3.7	0.1	1.0	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	2.9	3.9	0.7	2.5	0.1	0.6	0.0	0.1	1.0	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	26.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.2	11.6	6.3	1.1	3.1	0.1	0.0	0.0	0.4	0.0	5.1	3.7	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.6	0.2	0.2	1.1	1.0	0.1	0.4	0.1	0.1	2.1	5.2	4.4	4.9	2.0	1.8	1.4	3.0	1.0	1.5
C21orf33	"D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Chromosome 21 open reading frame 33"	P30042	21	44133605-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.0;U-266/70: 36.5;U-266/84: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"		1800000	Mitochondria	Centrosome	"HPA018517: "	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	16.0	9.6	9.1	6.1	11.4	2.2	7.2	7.9	16.6	5.1	11.7	11.6	12.4	3.0	6.6	22.8	7.6	7.3	5.2	29.2	8.4	8.7	31.6	36.8	8.5	9.9	10.9	9.2	6.7	15.7	2.0	6.5	5.6	8.3	11.0	1.9	6.6	8.8	8.0	45.9	13.4	7.7	7.6	7.3	8.9	13.7	11.8	5.1	5.8	7.1	21.0	15.2	5.1	4.7	22.5	12.3	8.9	20.7	14.7	15.6	23.9	0.4	1.6	0.9	0.2	9.3	8.9	13.9	18.1	10.3	14.3	10.9	21.7	0.2	43.0	0.3	0.1	0.2	0.1	8.6	6.4	9.5	20.9	1.2	3.5	11.6	10.4	0.6	0.3	0.1	0.9	3.9	0.7	0.7	8.1	13.6	5.0	1.6	0.4	1.2	0.4	0.6	0.4	0.1	15.2	0.9	0.3	14.3	0.2	0.2	0.5	14.0	1.0	1.5	8.8	5.5	0.3	10.8	0.1	36.5	30.4	0.9	0.5	2.8	6.5	8.9	11.3	6.8	13.0	13.3	11.3	22.5	15.5	15.6	4.6	21.6	14.8	12.8	5.1	14.7	20.7	12.3	14.6	23.9	9.1	11.4	7.9	16.6	8.4	8.7	10.9	9.2	8.3	5.1
C6orf106	"dJ391O22.4, FLJ22195"	ENSG00000196821	"Chromosome 6 open reading frame 106"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Approved	"Nuclear speckles,Centrosome"				"Nuclear speckles"	Centrosome	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	16.5	10.7	12.5	13.7	12.7	7.5	15.2	22.5	18.7	9.5	22.4	6.3	6.7	9.1	9.0	15.5	13.7	8.6	15.9	60.4	11.2	10.0	23.9	35.2	16.9	10.1	14.4	6.8	11.6	12.0	14.1	7.3	11.1	9.0	9.0	9.5	10.3	12.6	16.1	66.3	10.4	14.9	12.3	7.8	9.1	10.0	20.7	8.2	5.8	15.7	26.6	13.3	13.4	11.4	8.6	4.1	18.2	7.3	5.7	9.2	4.7	29.5	13.4	13.5	19.6	32.1	17.7	15.8	20.1	23.6	24.0	30.1	26.3	13.9	33.8	15.2	19.9	29.4	38.9	16.9	30.6	47.6	15.2	28.3	15.7	25.1	31.4	23.7	31.6	11.9	35.4	24.1	22.0	18.9	31.8	14.4	13.5	17.6	16.6	16.4	12.3	12.1	13.1	17.1	18.0	18.8	29.6	16.0	12.5	30.0	14.7	29.5	18.6	20.0	19.1	19.9	15.3	20.7	19.9	20.6	46.7	26.3	7.1	21.1	23.1	18.2	3.5	7.3	9.1	6.3	4.8	6.7	6.6	7.2	4.1	8.6	3.6	5.7	4.5	5.7	7.3	2.2	9.2	4.7	12.5	12.7	22.5	18.7	11.2	10.0	14.4	6.8	9.0	8.2
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA050835: , HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.1	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.1	2.6	2.7	0.4	0.5	0.4	2.7	0.2	1.4	0.7	0.4	1.5	9.1	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.6	0.4	1.9	0.0	0.0	3.3	0.4	5.9	0.1	0.1	7.9	3.6	18.7	5.4	1.5	0.6	2.1	19.6	4.2	1.8	0.5	0.1	6.0	0.1	0.0	20.4	8.9	1.9	3.3	2.2	3.3	2.7	4.7	1.1	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595902-7618304	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;Hep G2: 11.2;SK-BR-3: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: "	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.8	2.8	8.0	1.9	9.2	0.9	4.1	12.0	15.5	4.5	11.4	0.8	13.5	20.9	1.5	8.0	14.7	4.8	7.6	0.9	5.2	4.8	9.7	14.2	4.5	1.1	2.6	6.5	1.0	15.7	4.2	6.2	3.6	7.0	6.7	4.1	8.8	22.1	16.0	1.1	33.9	17.7	1.0	1.0	1.1	14.5	9.1	1.1	0.9	9.6	2.5	5.7	4.1	6.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	8.3	1.3	0.2	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	19.7	4.4	2.3	3.6	0.0	7.4	3.2	2.1	0.0	1.5	7.6	0.0	0.3	11.2	0.0	0.0	3.4	0.0	4.2	0.0	0.3	0.0	0.7	0.0	0.0	9.4	0.1	0.1	5.1	3.6	0.5	0.0	2.7	1.5	4.4	6.4	6.8	1.0	9.7	0.0	8.0	1.3	0.0	0.0	1.6	0.0	0.3	3.9	0.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.0	9.2	12.0	15.5	5.2	4.8	2.6	6.5	7.0	1.1
CCDC92	FLJ22471	ENSG00000119242	"Coiled-coil domain containing 92"	Q53HC0	12	123918660-123972831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038560, HPA057580"	Approved		Supported	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA038560: AB_10672717, HPA057580: "	"unprognostic (4.77e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (7.15e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.14e-2)"	"prognostic favourable (4.59e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	19.3	11.1	35.2	9.4	24.6	3.8	16.3	17.0	34.5	11.4	11.7	16.4	6.0	14.4	11.8	18.6	8.9	12.6	10.6	23.6	33.6	26.5	11.5	11.0	20.1	8.2	27.2	23.0	13.0	11.8	18.3	14.9	17.3	34.2	11.2	7.8	13.6	9.0	12.9	22.3	7.7	14.2	14.2	22.4	9.4	11.1	24.0	13.0	8.0	15.3	4.9	6.6	10.7	12.7	1.7	1.3	4.6	1.3	1.3	3.7	1.8	4.0	4.5	2.3	4.0	15.2	8.4	4.1	6.8	12.9	3.8	4.1	2.4	1.2	1.9	2.4	8.5	2.8	2.5	1.7	2.6	12.6	5.9	2.5	1.6	1.5	8.1	0.4	9.7	4.7	7.8	4.8	3.0	10.6	2.5	0.9	3.4	2.7	2.4	4.4	1.0	10.1	3.1	1.3	0.5	5.2	4.2	4.4	6.3	3.3	1.7	4.6	4.8	2.2	10.5	7.7	1.7	4.9	2.3	3.2	1.7	0.6	6.1	3.4	3.2	4.6	1.3	1.9	2.3	0.7	3.7	1.6	3.0	3.5	1.0	1.7	2.3	2.8	1.2	1.3	0.1	1.3	0.5	1.8	35.2	24.6	17.0	34.5	33.6	26.5	27.2	23.0	34.2	13.0
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510675-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA049352: "	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favourable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	17.7	14.2	36.8	6.9	41.6	5.1	8.2	36.4	54.6	13.6	9.5	16.3	2.7	30.0	13.4	4.4	8.0	10.9	9.5	25.0	33.8	37.1	23.7	13.2	9.6	8.2	34.2	38.9	18.7	22.9	10.4	19.3	8.5	26.3	13.2	4.1	7.8	10.8	14.7	34.0	9.1	24.2	8.7	20.7	12.0	9.2	10.1	15.7	13.0	10.6	6.7	6.9	7.8	6.3	8.7	9.2	19.3	19.2	14.3	15.9	7.2	3.8	1.6	5.4	1.6	0.4	0.0	0.1	5.9	0.9	5.8	5.0	9.3	1.5	0.2	6.0	4.8	0.1	4.9	20.8	1.0	13.1	9.3	17.6	6.2	24.1	3.9	8.5	11.0	5.7	10.8	5.2	0.8	4.6	0.3	4.8	6.5	0.4	6.6	11.1	12.0	4.6	25.0	4.8	48.1	1.2	0.1	16.3	7.0	11.8	0.5	7.3	2.1	4.7	0.2	3.0	8.9	2.0	0.2	12.9	11.9	17.8	0.1	8.6	2.0	3.2	7.9	19.3	15.9	12.5	8.6	8.7	5.7	8.9	7.6	8.3	11.4	9.7	6.2	14.3	19.2	9.2	9.1	7.2	36.8	41.6	36.4	50.3	33.8	37.1	34.2	38.9	26.3	15.7
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"				Centrosome	"Cell Junctions"	"CAB079753: , HPA035820: AB_10671939, HPA046529: "	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.8	23.3	14.0	10.1	14.9	12.5	12.3	9.5	14.0	13.1	13.2	12.6	17.8	5.7	12.0	21.0	18.4	14.1	13.5	14.2	7.4	15.2	30.8	23.3	9.5	18.7	10.2	26.8	9.4	12.4	16.4	12.1	14.0	15.5	18.3	21.5	20.0	12.0	21.6	12.7	19.7	27.9	8.4	10.0	7.6	15.3	17.6	21.4	11.8	14.2	27.6	12.9	8.1	12.2	13.3	14.2	13.9	11.3	15.7	20.0	12.7	12.0	25.5	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7
CDKL2	"KKIAMRE, P56"	ENSG00000138769	"Cyclin dependent kinase like 2"	Q92772	4	75578005-75630716	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.7"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HEK 293: 3.7;HHSteC: 4.3;RPTEC TERT1: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040672			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA040672: AB_10794744"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.80e-5)"	"unprognostic (3.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.88e-15)"	"unprognostic (5.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.52e-2)"	0.7	2.4	7.1	1.2	11.1	0.7	1.2	7.7	13.2	1.7	2.0	6.2	0.0	1.0	1.7	2.3	2.3	4.1	1.4	1.3	5.1	6.7	11.8	0.7	9.2	1.3	7.1	7.0	3.8	1.6	5.7	8.9	0.7	12.5	2.0	2.4	3.4	1.2	2.0	0.7	0.9	0.9	1.5	7.4	0.9	1.5	27.7	6.1	0.0	6.9	0.0	2.0	1.1	0.9	0.4	0.0	0.2	0.0	0.0	1.6	0.1	5.6	0.7	0.3	0.0	0.3	0.3	0.0	0.3	1.7	2.4	1.9	0.5	1.2	0.1	0.9	0.1	0.8	0.0	0.5	2.2	0.2	3.7	0.0	0.2	0.0	4.3	0.0	0.1	1.4	2.1	0.4	0.8	0.1	0.0	0.4	0.9	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	8.1	0.3	3.0	2.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.4	1.6	0.0	0.0	0.6	0.5	0.2	0.0	0.0	0.0	1.2	0.1	7.1	11.1	7.7	13.2	5.1	6.7	7.1	7.0	12.5	6.1
CEP164	"KIAA1052, NPHP15"	ENSG00000110274	"Centrosomal protein 164"	Q9UPV0	11	117314557-117413268	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis"		"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037605, HPA037606, HPA061504"	Uncertain		Enhanced	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA037605: AB_10672908, HPA037606: AB_10672498, HPA061504: "	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.90e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.93e-2)"	7.1	6.8	7.8	11.2	10.4	7.0	7.2	17.4	7.8	10.5	6.8	9.1	11.2	4.7	17.4	9.4	9.7	12.9	12.1	4.6	6.9	6.8	7.1	7.2	7.3	7.7	7.4	8.3	13.9	28.1	10.8	19.1	5.1	8.2	7.4	5.8	16.4	6.9	7.6	3.1	8.3	6.2	11.5	10.4	9.7	6.3	29.7	8.3	10.8	9.6	5.0	14.4	8.0	8.0	18.0	21.1	36.5	16.6	11.8	21.4	4.3	8.8	12.4	9.1	18.2	9.2	15.8	2.9	17.7	9.9	12.7	12.5	15.3	14.5	17.6	12.8	10.9	11.8	10.1	10.4	10.9	17.4	8.4	5.3	12.2	4.8	13.6	7.6	11.9	10.9	8.9	19.3	18.8	16.4	14.4	11.6	9.9	7.7	7.0	6.9	6.5	13.5	9.4	10.9	6.9	5.6	7.7	10.7	15.5	14.0	8.6	10.1	11.8	8.9	17.7	15.2	9.5	14.6	16.1	4.1	5.0	10.5	7.4	8.7	10.0	30.7	15.7	9.4	15.9	12.9	10.1	15.2	20.0	17.9	5.8	18.0	18.9	15.1	36.5	11.8	16.6	21.1	21.4	4.3	7.8	10.4	17.4	7.8	6.9	6.8	7.4	8.3	8.2	8.3
CEP170B	"Cep170R, FAM68C, KIAA0284"	ENSG00000099814	"Centrosomal protein 170B"	Q9Y4F5	14	104865280-104896770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000871, HPA059017"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA000871: , HPA059017: "	"unprognostic (1.09e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (4.41e-4)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.17e-2)"	10.3	8.8	19.9	7.3	26.3	1.3	10.9	25.9	39.7	6.6	18.0	5.3	9.1	24.7	7.4	5.0	14.7	8.5	15.1	4.9	18.5	12.4	9.9	9.4	8.0	2.1	8.9	19.7	4.6	25.4	9.0	10.5	4.8	13.5	10.3	8.9	5.3	17.5	12.5	4.6	35.0	24.6	6.7	6.5	3.8	23.2	10.9	6.0	0.2	10.1	6.2	5.6	8.8	11.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	10.8	9.0	0.7	8.6	3.6	2.7	20.1	8.6	3.4	4.3	2.9	9.5	6.7	0.0	10.5	6.5	24.1	2.0	10.0	1.1	4.0	4.2	0.0	9.6	6.2	7.4	0.0	8.9	2.6	12.8	4.5	6.6	4.3	2.7	0.1	3.6	22.9	0.0	0.1	2.8	7.8	3.6	0.0	2.6	4.3	18.5	2.3	2.4	12.7	7.5	11.4	13.1	1.6	9.5	6.9	7.6	18.9	5.7	0.4	0.0	0.0	5.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	19.9	26.3	25.9	39.7	18.5	12.4	8.9	19.7	13.5	6.0
CEP192	"FLJ10352, KIAA1569, PPP1R62"	ENSG00000101639	"Centrosomal protein 192"	Q8TEP8	18	12991362-13125052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039392, HPA040503"	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039392: AB_10697549, HPA040503: AB_10670919"	"unprognostic (6.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.66e-3)"	7.6	6.5	7.9	14.9	11.8	16.3	8.3	14.5	11.8	8.8	7.7	11.1	7.1	6.7	13.6	9.3	7.6	8.8	9.9	7.1	8.1	4.7	6.9	6.1	8.7	11.0	8.7	11.8	17.4	9.5	10.4	11.1	7.8	11.8	8.0	9.4	7.9	10.4	6.6	6.2	8.2	9.6	9.5	7.6	8.4	8.2	16.4	9.8	18.3	11.1	6.0	12.2	12.1	8.6	3.9	1.8	2.1	4.9	0.9	3.5	1.0	9.9	5.4	14.8	7.7	6.5	10.1	4.8	7.0	9.3	11.1	11.8	7.4	4.4	11.3	4.7	7.1	4.9	12.8	6.6	13.2	4.4	4.6	10.3	8.3	3.9	3.4	16.3	7.9	6.9	2.5	9.3	8.5	9.1	14.1	7.6	8.6	5.0	14.0	7.1	4.7	3.4	12.1	11.6	5.8	3.8	10.2	10.8	6.1	11.2	5.6	3.5	4.4	8.4	9.1	8.8	20.8	10.0	9.6	5.1	7.3	12.9	5.6	7.4	8.4	1.5	2.1	1.5	3.2	1.5	2.4	1.8	2.1	2.0	0.9	3.9	2.3	3.5	2.1	0.9	4.9	1.8	1.8	1.0	7.9	11.8	14.5	11.8	8.1	4.7	8.7	11.8	11.8	9.8
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.1;REH: 35.6;U-266/70: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol			560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavourable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.6	8.5	3.2	0.7	3.1	1.7	0.0	2.6	3.5	1.4	2.0	0.2	6.9	0.0	8.3	10.5	14.4	0.6	8.3	1.2	0.0	2.4	0.0	3.9	6.3	1.0	0.0	16.3	1.0	9.6	3.9	3.3	2.8	0.0	27.1	6.9	7.0	0.0	0.0	2.8	0.0	35.6	4.3	8.4	7.0	1.2	0.3	0.7	6.8	3.9	0.0	2.8	0.0	3.3	0.3	0.1	10.0	0.4	24.6	5.9	6.8	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7
CLHC1	"C2orf63, FLJ31438"	ENSG00000162994	"Clathrin heavy chain linker domain containing 1"	Q8NHS4	2	55174791-55232563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045418, HPA053557"	Uncertain		Approved	"Nucleoli fibrillar center,Centrosome"				"Nucleoli fibrillar center, Centrosome"		"HPA045418: AB_10962144, HPA053557: "	"unprognostic (1.60e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-4)"	"unprognostic (6.36e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (2.15e-4)"	4.8	5.7	10.4	3.6	8.7	3.5	6.7	15.7	11.9	6.0	5.3	12.9	9.3	3.9	8.5	9.8	5.5	9.5	6.2	4.6	8.2	5.1	5.2	3.5	5.3	6.6	6.0	8.3	7.4	5.5	8.4	23.6	6.9	8.9	9.1	6.6	8.9	5.8	8.9	3.0	9.6	5.6	7.1	12.0	7.2	4.9	23.2	8.8	10.1	8.3	1.6	5.2	6.6	6.1	1.3	2.9	4.0	2.0	3.2	2.1	1.0	4.3	3.2	8.3	4.9	3.4	4.7	7.2	5.7	5.4	2.9	2.7	6.3	4.0	6.4	3.4	2.6	6.6	3.5	4.9	6.0	5.7	4.1	9.3	9.7	5.7	3.7	5.6	4.6	6.6	4.0	3.6	8.4	2.9	4.7	3.8	3.3	3.5	4.1	6.3	3.0	1.3	5.0	4.7	4.0	4.6	5.1	9.5	5.8	3.3	5.4	5.4	4.1	3.1	8.4	7.3	4.9	3.4	4.0	7.6	1.9	3.7	5.4	5.7	1.8	1.2	0.6	4.0	0.9	2.0	0.1	1.2	1.7	0.9	1.0	1.3	2.1	1.0	0.4	3.2	1.6	2.9	1.1	1.0	10.4	8.7	15.7	11.9	8.2	5.1	6.0	8.3	8.9	8.8
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA020468: , HPA020480: , HPA051583: "	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.3	3.6	10.0	7.2	1.5	2.3	1.7	3.7	2.8	2.9	2.5	2.1	5.9	24.6	1.4	2.7	11.3	3.3	2.2	4.8	14.9	2.6	12.8	6.5	2.5	2.1	34.8	15.6	1.4	1.7	3.1	7.5	6.4	8.3	14.1	2.8	3.4	13.6	11.9	3.4	2.9	12.9	15.1	7.0	1.4	2.5	3.8	5.7	12.7	2.3	2.9	4.9	16.7	4.7	3.1	5.4	4.8	6.8	9.8	10.7	16.7	2.6	14.4	7.1	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949918	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	9.0	7.4	7.5	9.2	10.1	18.4	9.3	11.2	12.7	13.0	10.9	9.8	9.9	6.8	21.3	12.6	11.0	10.4	9.0	7.1	9.5	8.0	9.2	8.7	15.0	8.4	9.3	9.9	11.4	11.0	16.5	9.6	9.9	9.9	9.9	12.5	10.3	9.6	8.6	6.8	16.9	9.1	16.3	7.0	9.9	8.4	51.2	6.4	16.0	10.4	6.2	11.2	9.3	10.0	2.1	7.6	9.4	3.4	3.4	3.5	2.6	22.1	14.5	21.8	12.0	9.2	12.7	7.1	19.3	18.1	27.1	20.8	12.3	8.3	22.8	10.3	16.9	17.9	16.8	13.5	30.3	22.4	13.2	15.1	23.8	9.7	13.6	14.0	23.4	11.6	10.0	19.0	19.2	16.7	10.9	11.2	18.7	7.2	21.2	13.5	4.8	11.4	22.6	14.9	8.5	12.5	6.8	7.1	12.8	15.6	8.0	6.2	10.9	8.9	13.6	15.1	12.8	20.5	26.6	17.2	11.5	15.8	13.0	17.9	21.5	9.4	2.5	1.0	2.9	3.4	2.6	2.1	2.2	3.5	1.7	1.5	1.4	2.4	0.4	3.4	1.4	7.6	2.9	2.6	7.5	10.1	11.2	12.7	9.5	8.0	9.3	9.9	9.9	6.4
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.4	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	29.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.2	0.6	55.5	32.7	4.9	0.0	0.0	42.4	26.8	0.0	0.1	0.3	0.2	0.0	1.7	1.0	7.1	0.6	0.6	3.7	0.5	0.0	2.5	0.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5
CROCC	"ROLT, rootletin"	ENSG00000058453	"Ciliary rootlet coiled-coil, rootletin"	Q5TZA2	1	16740273-16972979	"Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 135.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA021191, HPA021762"	Enhanced		Supported	"Plasma membrane,Centrosome"				"Plasma membrane, Centrosome"		"HPA021191: AB_1856395, HPA021762: AB_1856396"	"unprognostic (9.07e-3)"	"unprognostic (9.03e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (8.34e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.42e-3)"	"prognostic favourable (7.92e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.76e-3)"	5.0	3.8	3.2	3.2	7.0	2.1	2.5	12.9	3.0	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5.0	4.2	3.0	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3.0	1.0	1.0	1.1	0.2	1.9	10.9	2.8	1.2	4.9	0.8	2.2	0.1	0.9	5.8	5.0	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.6	0.7	2.8	0.3	3.5	3.3	1.2	11.6	2.7	3.1	4.2	3.7	0.7	1.1	9.8	10.6	3.2	2.1	9.7	4.2	1.4	4.3	2.8	3.7	7.0	2.3	5.0	3.6	2.2	2.7	0.7	3.3	0.0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7.0	12.9	3.0	4.6	3.5	2.1	2.5	11.3	4.3
CXorf56	FLJ22965	ENSG00000018610	"Chromosome X open reading frame 56"	Q9H5V9	X	119538149-119565408	"Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038245, HPA038617, HPA064831"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: "	"prognostic unfavourable (3.45e-4)"	"unprognostic (3.88e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.92e-2)"	"unprognostic (7.74e-3)"	"unprognostic (6.38e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.68e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.90e-1)"	15.9	14.5	18.7	12.7	29.1	19.1	21.1	21.0	24.2	15.0	15.6	18.3	15.1	12.3	17.6	14.5	13.6	17.6	12.4	16.3	16.0	20.5	18.2	14.3	14.6	15.7	18.0	21.3	24.0	16.3	20.5	12.6	29.0	20.2	15.3	15.0	18.6	14.6	16.1	16.4	17.4	12.5	16.2	17.8	15.0	13.0	12.7	17.6	12.8	20.2	13.2	19.0	14.4	13.1	19.4	12.0	16.8	15.4	7.7	12.9	10.9	17.0	20.0	12.1	13.8	13.8	10.1	15.5	11.8	12.1	18.5	16.7	17.3	17.3	27.0	29.6	13.7	11.4	30.5	15.6	26.0	16.2	23.0	9.6	18.2	11.6	11.0	26.6	15.5	11.1	13.5	22.6	19.4	12.9	21.6	17.3	9.0	29.9	16.7	14.0	18.1	20.8	16.3	12.5	20.3	11.1	13.4	8.3	14.6	22.8	12.7	15.8	10.5	11.6	12.4	11.2	7.8	20.6	24.8	15.0	26.5	27.5	10.1	26.1	14.2	5.7	12.8	16.8	12.4	15.4	11.4	13.5	10.8	12.9	12.0	19.4	11.1	10.5	6.5	7.7	14.1	11.3	12.4	10.9	18.7	29.1	21.0	24.2	16.0	20.5	18.0	21.3	20.2	17.6
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: "	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.1	27.9	27.9	13.3	27.3	41.0	25.7	30.3	36.5	19.8	15.9	32.4	17.7	15.9	20.6	27.6	20.0	18.4	16.5	20.6	27.3	29.0	20.0	22.0	17.8	13.3	30.8	24.0	26.3	32.5	23.9	27.7	25.9	33.2	24.1	18.6	21.3	15.7	22.4	42.0	19.0	15.4	21.3	34.7	13.9	18.0	22.9	25.4	18.8	24.8	15.3	14.5	23.3	16.2	5.0	10.9	16.4	10.7	3.0	6.9	5.2	9.4	11.3	20.5	34.2	25.1	24.3	16.9	16.7	16.8	20.2	20.4	21.1	11.9	9.2	23.4	19.8	11.5	25.2	19.6	24.8	18.5	19.8	11.9	13.1	13.2	22.9	14.3	17.0	24.5	17.5	18.1	31.8	14.3	18.1	11.9	26.1	9.9	8.8	7.7	10.3	17.8	7.8	12.4	10.2	15.0	16.2	46.6	19.6	17.7	24.2	24.8	23.4	19.2	15.9	22.6	12.7	14.7	17.6	10.6	13.5	5.5	26.0	19.3	18.4	3.2	10.7	10.5	5.5	7.8	5.6	5.0	6.2	5.4	10.9	4.4	5.9	6.9	16.4	3.0	6.4	5.1	4.3	5.2	27.9	27.3	30.3	33.3	27.3	29.0	30.8	24.0	33.2	25.4
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964510-102056443	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol			120000	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavourable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	23.3	17.2	24.3	13.9	42.9	21.1	12.7	43.9	53.4	16.9	18.4	35.0	10.2	13.9	18.6	12.5	18.3	15.5	16.1	26.6	26.1	26.6	11.2	9.4	14.6	14.0	29.1	23.4	24.7	15.4	28.1	16.4	14.8	51.5	16.7	11.9	15.5	18.0	18.6	44.5	42.0	13.8	17.7	30.3	15.4	15.5	17.2	12.6	15.1	18.1	11.1	12.9	19.1	12.8	2.7	6.3	4.5	6.0	7.8	4.7	3.3	23.8	35.7	19.7	15.1	44.1	28.8	12.0	20.7	19.3	24.4	21.5	15.2	12.1	13.7	17.0	28.2	21.8	19.2	23.1	8.9	11.8	11.6	9.8	23.3	24.6	20.1	14.4	10.2	18.7	12.2	57.6	43.0	26.7	8.4	15.7	27.7	23.4	9.4	3.6	11.9	44.2	8.9	20.7	7.8	19.7	38.0	22.4	18.1	27.3	13.9	18.0	11.5	6.1	58.6	29.0	12.4	40.0	28.2	10.8	10.9	9.2	39.9	8.6	17.8	3.6	3.4	2.5	4.6	6.0	4.7	2.2	3.0	4.0	6.3	2.7	3.6	4.2	4.5	7.8	3.9	3.3	3.0	3.3	24.3	42.9	43.9	53.4	26.1	26.6	29.1	23.4	51.5	12.6
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525971-32570874	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	16.1	11.6	15.8	14.8	18.6	27.5	18.9	24.5	28.0	13.4	13.8	12.7	9.2	11.6	17.0	11.6	13.9	14.7	14.1	40.1	16.3	23.4	18.4	15.9	16.3	15.8	18.3	16.4	15.2	18.6	16.8	18.9	14.9	26.5	18.6	14.2	14.1	12.0	12.9	41.1	32.1	13.0	19.7	16.6	18.1	13.8	34.0	11.7	19.3	12.8	16.6	17.2	15.5	13.5	6.2	15.3	29.8	25.1	7.5	6.1	10.7	13.1	14.2	22.1	13.8	12.7	15.0	61.0	20.3	28.0	36.7	30.2	15.0	11.3	16.4	13.8	20.5	6.8	22.1	15.9	35.1	15.5	15.3	21.7	10.4	13.4	15.6	24.6	12.8	12.1	12.7	25.8	20.3	23.6	25.1	15.2	19.6	10.5	18.8	10.9	22.8	19.1	16.6	11.8	17.1	14.9	12.0	9.5	14.0	14.3	17.7	15.3	14.7	14.4	17.5	20.2	17.0	17.5	20.3	11.0	27.7	26.6	11.3	21.3	15.7	11.3	13.3	11.7	5.2	16.8	5.4	6.1	5.6	5.7	15.3	6.2	3.9	5.0	29.8	7.5	25.1	8.4	6.1	10.7	15.8	18.6	24.5	28.0	16.3	23.4	18.3	16.4	26.5	11.7
DYNC1LI2	DNCLI2	ENSG00000135720	"Dynein cytoplasmic 1 light intermediate chain 2"	O43237	16	66720893-66751798	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057201			Approved	Centrosome,Cytosol				Centrosome	Cytosol	"HPA057201: "	"unprognostic (6.03e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.34e-1)"	26.5	21.4	63.8	16.8	63.5	16.7	19.0	28.8	43.3	23.0	24.4	61.2	17.6	19.5	23.9	19.5	23.7	17.9	22.5	26.6	68.3	48.3	20.3	13.0	20.8	11.0	75.0	28.9	22.1	20.2	44.7	19.3	21.1	51.1	25.3	28.7	13.6	20.8	24.5	17.2	23.1	19.8	30.1	89.5	15.5	22.6	14.9	55.0	6.7	28.8	7.9	12.6	20.4	20.0	9.0	12.1	16.3	17.1	8.2	14.9	7.9	15.0	15.8	23.5	21.0	30.4	30.2	21.4	24.6	19.7	20.2	26.3	21.4	14.8	6.3	19.6	24.1	21.8	18.0	17.6	29.6	4.2	13.0	7.7	18.3	20.2	16.9	8.1	11.5	19.7	24.2	23.2	16.1	28.3	12.5	8.3	26.1	10.7	5.1	10.7	14.1	27.5	11.2	49.7	7.5	20.1	21.2	23.6	16.5	44.4	9.6	28.5	11.7	8.2	35.9	26.2	13.1	12.8	16.7	10.6	7.7	12.5	22.5	7.9	16.4	10.1	17.1	16.1	13.4	9.8	14.9	5.2	11.3	10.7	12.1	9.0	9.6	9.1	16.3	8.2	13.1	7.6	10.9	7.9	63.8	63.5	28.8	43.3	68.3	48.3	75.0	28.9	51.1	55.0
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"salivary gland: 39.7"	"Cell line enriched"	"Detected in many"	7	"RH-30: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA043020: , HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	9.3	6.1	3.1	3.8	3.0	1.6	10.1	3.7	3.8	8.9	5.4	2.5	8.7	2.8	10.1	8.1	6.4	7.2	8.3	3.9	2.5	1.6	10.8	6.1	7.2	5.5	2.1	2.7	10.7	34.4	6.0	3.6	4.5	3.5	7.7	3.7	6.1	39.7	14.6	2.8	6.2	3.3	7.0	2.9	3.8	6.0	4.3	1.4	1.5	8.4	5.1	6.2	7.7	6.9	0.7	3.9	1.2	5.4	1.8	10.6	2.6	1.9	3.4	1.8	2.1	5.2	4.9	1.5	2.1	4.3	3.6	3.6	2.0	3.2	1.1	2.4	2.9	1.9	1.3	1.3	3.6	1.1	2.0	5.5	1.9	3.5	4.6	1.3	2.4	5.2	3.4	3.7	3.9	3.8	3.3	8.7	2.1	1.4	1.6	3.9	1.3	3.2	3.2	58.0	3.7	2.4	2.2	1.7	2.3	3.8	2.8	2.3	4.6	3.6	3.6	5.4	3.0	2.2	2.2	1.9	0.8	1.4	4.1	5.8	3.6	0.5	3.9	0.1	2.5	1.5	10.6	0.7	4.9	2.9	3.9	0.7	2.5	1.9	1.2	1.8	5.4	2.0	3.0	2.6	3.1	3.0	3.7	3.8	2.5	1.6	2.1	2.7	3.5	1.4
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA062681: "	"unprognostic (2.21e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavourable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	30.6	30.2	13.2	13.8	9.5	7.7	25.5	22.0	10.8	18.1	16.7	18.2	11.5	19.3	32.1	10.2	29.6	15.3	15.5	13.1	18.6	57.1	14.0	21.2	25.3	13.8	9.7	14.4	9.6	17.7	16.6	11.7	13.7	17.5	14.0	13.2	18.6	19.8	28.6	19.0	34.1	18.5	12.3	18.3	25.3	8.7	10.9	19.8	18.1	14.2	23.4	16.5	10.5	15.0	15.2	18.9	22.9	32.2	13.7	15.1	12.7	23.8	12.7	18.2	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favourable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.6	3.4	6.2	3.6	1.5	6.5	3.4	1.7	2.8	2.0	5.1	4.9	0.0	4.2	3.5	6.7	5.4	3.7	1.6	2.7	7.2	4.0	9.8	3.0	2.7	4.6	7.7	4.0	5.2	2.4	2.7	2.9	5.8	2.8	1.8	3.8	0.4	4.4	1.5	8.7	8.5	11.6	2.9	1.5	12.7	2.8	5.7	5.5	25.5	2.5	9.0	4.4	3.8	5.5	4.1	4.8	3.4	6.8	1.2	1.9	2.3	8.5	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202635188-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: "	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	5.8	12.5	10.1	11.1	10.3	4.3	10.0	20.8	18.1	5.5	7.9	3.2	7.1	7.0	5.0	7.5	9.6	6.6	6.2	4.3	8.6	10.8	8.3	3.6	6.2	13.0	5.9	9.1	8.8	11.6	24.7	7.5	11.0	4.7	8.6	7.9	3.7	8.6	9.3	5.8	9.0	6.0	7.3	5.7	8.2	6.6	12.6	5.8	22.4	5.5	4.8	11.7	7.2	12.7	9.0	4.8	2.3	8.9	4.5	9.9	3.3	1.5	2.0	8.8	6.0	3.0	1.7	8.5	0.5	0.8	0.5	1.0	2.5	3.4	6.6	5.4	0.9	1.5	7.5	3.8	1.4	0.1	6.0	5.5	3.8	9.3	2.4	4.7	2.5	2.3	5.3	1.1	1.6	2.3	7.9	1.3	0.5	3.2	12.6	9.8	8.9	3.8	10.0	1.8	7.8	4.7	4.2	14.9	12.9	6.6	4.4	3.1	1.8	6.5	1.4	1.1	2.0	1.5	0.9	4.9	2.8	8.8	2.0	3.6	1.1	0.3	4.5	1.6	1.6	8.9	4.0	9.0	3.6	3.1	4.8	8.5	9.9	6.8	2.3	4.5	8.8	1.7	1.3	3.3	10.1	10.3	20.8	18.1	8.6	10.8	5.9	9.1	4.7	5.8
FP565260.6		ENSG00000280071			21	5079294-5128425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"			Mitochondria	Centrosome	"HPA018517: "	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	3.9	6.7	2.8	2.0	6.6	1.3	3.4	8.2	7.0	3.0	5.7	5.2	2.5	5.7	2.2	5.0	3.9	3.3	2.8	15.5	3.2		12.9	14.4	4.8	10.5	6.7	4.7	5.6	2.7	4.0	0.9	6.4	4.2	3.0	4.7	4.4	4.9	2.3	17.1	1.3	3.6	2.4	3.0	2.6	2.2	1.4	3.9	1.1	4.2	11.1	2.4	3.9	2.0	47.1	43.8	19.9	46.4	37.1	41.4	46.1	13.1	12.4	13.8	24.2	13.2	12.6	6.7	0.0	2.6	0.8	1.2	2.0	13.5	1.2	15.3	16.2	9.5	19.9	10.4	1.2	9.0	8.9	51.0	13.2	12.6	12.0	21.9	9.7	20.1	17.4	8.0	14.6	16.0	20.0	15.2	9.5	27.5	21.9	24.0	26.9	20.3	44.9	10.4	47.8	18.1	12.2	13.9	23.5	18.3	34.4	12.8	35.3	30.8	5.7	7.9	9.8	0.8	8.0	20.5	20.9	8.6	16.3	45.4	6.6	19.9	33.6	16.9	31.6	36.0	31.6	43.9	41.4	32.9	43.8	47.1	39.7	30.2	6.8	37.1	46.4	28.9	40.0	46.1										
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell line enhanced"	"Detected in many"		"A549: 16.2"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA042666: "	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.4	16.2	4.5	6.8	0.0	0.0	3.8	1.3	0.0	0.0	0.0	9.8	7.4	7.4	2.1	0.0	5.4	0.0	0.0	0.0	7.2	7.9	4.9	10.3	5.0	0.1	4.4	5.9	0.0	0.0	0.0	0.0	0.0	11.8	4.4	0.0	13.8	1.7	2.1	6.1	2.2	5.2	3.2	5.7	0.0	4.4	8.1	3.7	1.6	4.1	4.8	3.4	1.9	1.5	5.2	5.8	1.3	1.8	12.1	3.2	4.3	2.8	8.0	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
GINS4	"MGC14799, SLD5"	ENSG00000147536	"GINS complex subunit 4"	Q9BRT9	8	41529206-41545046	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024663, HPA026580"	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA024663: AB_1857224, HPA026580: AB_1857225"	"unprognostic (7.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.25e-3)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.34e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-5)"	"unprognostic (2.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.22e-1)"	2.0	3.0	2.3	6.2	4.7	9.0	2.7	1.6	3.7	2.7	3.4	6.8	0.0	2.5	2.4	3.0	6.0	1.6	2.4	5.7	3.7	1.8	2.2	2.2	2.5	7.9	5.9	3.3	2.6	1.3	1.6	1.2	4.8	2.8	1.8	5.1	1.9	2.6	0.8	3.7	3.4	3.7	2.4	4.7	5.0	2.1	8.6	5.6	14.0	2.1	5.7	9.6	2.1	3.0	5.8	5.2	3.9	1.4	2.7	6.7	1.7	9.5	13.8	19.6	8.7	1.2	1.5	8.1	13.7	8.3	14.2	16.7	12.7	8.4	13.3	5.6	6.9	7.3	15.7	11.3	21.0	4.9	8.7	19.3	10.2	8.6	0.3	4.2	10.0	0.8	0.5	23.5	5.3	7.0	9.5	4.5	9.9	6.6	17.4	4.8	10.8	7.6	16.3	18.2	5.6	5.1	9.1	6.0	4.7	9.7	4.3	3.9	11.2	4.7	4.8	9.7	14.7	17.8	13.7	5.3	7.7	15.9	6.9	9.9	23.4	2.4	1.4	0.5	3.0	1.3	1.7	2.4	4.8	2.0	0.7	5.8	3.1	2.0	3.9	2.7	0.7	5.2	6.7	1.7	2.3	4.7	1.6	3.7	3.7	1.8	5.9	3.3	2.8	5.6
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"				Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.90e-10)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.5	10.2	20.2	15.9	0.4	1.2	9.7	18.7	8.8	27.4	22.6	10.7	8.2	20.4	5.0	7.2	11.3	18.1	4.7	17.6	12.2	19.5	13.6	14.4	8.2	0.0	24.4	16.7	0.2	0.3	11.7	6.0	11.8	10.4	25.7	16.3	12.0	21.8	12.0	14.1	11.6	21.7	22.7	13.4	4.5	3.9	10.5	14.3	17.9	11.7	8.2	9.9	9.4	9.3	15.6	29.6	12.7	19.6	14.7	7.0	20.7	9.9	11.8	22.7	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3
HAUS1	"CCDC5, FLJ40084, HEI-C, HsT1461"	ENSG00000152240	"HAUS augmin like complex subunit 1"	Q96CS2	18	46104332-46128333	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040601, HPA040652"	Supported		Supported	Centrosome,Cytosol				Cytosol	Centrosome	"HPA040601: AB_10794743, HPA040652: AB_10793966"	"unprognostic (1.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.39e-1)"	"unprognostic (4.76e-3)"	"prognostic favourable (1.55e-4)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (5.97e-3)"	"unprognostic (5.40e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.96e-2)"	15.2	11.8	10.3	14.6	13.1	23.1	14.5	15.8	12.2	14.3	13.4	6.2	13.1	9.9	15.5	28.4	15.9	13.8	11.6	9.3	10.3	8.0	14.4	12.1	10.9	22.9	13.6	6.8	20.4	12.0	6.5	18.1	13.0	12.0	14.8	16.3	7.3	11.4	14.4	7.1	8.6	13.4	12.2	14.4	17.9	12.2	11.8	15.4	38.4	14.3	14.4	26.1	13.9	12.3	28.1	23.4	13.0	18.2	19.3	34.9	19.3	18.4	11.2	42.5	22.9	10.9	16.9	11.4	18.1	18.1	28.9	28.8	10.9	10.5	35.3	10.9	12.9	19.7	25.4	15.3	31.9	19.8	17.0	25.9	12.0	20.6	9.2	47.2	15.9	8.2	6.1	17.8	9.2	31.5	18.4	10.1	25.8	10.8	37.4	22.6	27.1	6.6	37.5	30.5	25.2	22.8	13.0	20.0	20.8	16.8	5.8	13.6	8.5	23.0	17.8	17.0	11.5	7.3	18.8	11.8	17.9	32.7	10.8	40.1	19.4	4.4	18.2	13.0	16.0	16.4	17.7	28.1	21.6	18.9	21.6	23.7	15.4	18.1	2.0	19.3	12.7	23.4	34.9	19.3	10.3	13.1	15.8	12.2	10.3	8.0	13.6	6.8	12.0	15.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 23.0;HEK 293: 11.1;HMC-1: 14.1;K-562: 11.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	61	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA057432: "	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.8	3.8	1.8	0.0	0.0	0.2	0.1	2.1	1.9	3.1	23.0	1.4	0.1	4.0	0.0	0.0	7.9	11.1	7.5	0.6	0.0	4.9	0.0	14.1	3.7	0.0	5.6	0.0	6.4	11.2	0.2	5.5	0.0	1.8	0.0	0.0	0.0	0.0	4.3	1.5	4.5	1.9	0.0	0.0	0.6	0.0	2.8	0.4	1.4	2.5	0.3	0.2	0.8	0.2	1.9	3.9	0.7	1.5	0.0	2.1	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1										
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: , HPA061446: "	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favourable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	8.9	11.8	6.4	10.1	4.4	4.5	7.4	4.1	1.7	4.0	4.4	8.6	4.1	0.0	7.5	1.1	2.1	37.3	14.7	5.5	16.7	11.1	4.8	16.2	10.4	1.6	18.5	8.2	4.1	13.7	2.6	9.4	5.1	8.5	5.5	4.9	6.5	5.8	1.6	1.5	9.8	0.0	0.7	0.9	13.5	4.1	11.8	4.3	7.4	12.9	0.6	9.8	3.1	1.4	1.4	0.0	1.7	9.8	10.8	12.4	2.8	5.4	12.6	4.2	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2
IFT81	"CDV-1R, CDV1, MGC4027"	ENSG00000122970	"Intraflagellar transport 81"	Q8WYA0	12	110124335-110218797	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019087, HPA020051"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA019087: AB_1851462, HPA020051: AB_1851465"	"unprognostic (2.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.45e-1)"	5.3	9.6	8.9	4.6	13.2	1.7	9.2	14.4	11.9	12.6	11.5	6.6	18.8	3.0	14.9	19.6	6.4	18.8	8.9	7.3	8.9	8.5	10.0	4.4	8.5	3.0	5.9	8.4	14.7	5.1	21.8	30.4	5.2	10.7	13.7	6.2	11.8	8.9	15.5	6.4	5.9	4.6	17.7	8.5	4.0	7.4	29.8	8.4	6.2	14.3	5.4	3.1	13.5	10.4	1.8	3.5	3.0	1.3	2.1	1.9	1.3	7.3	13.9	28.7	12.1	5.3	10.9	2.1	4.7	7.2	10.1	8.7	2.6	4.1	2.4	2.6	8.9	6.5	10.5	5.5	13.2	3.0	5.7	5.0	8.2	4.3	4.5	3.1	2.4	7.8	6.2	9.5	2.4	6.3	6.1	1.3	9.3	1.5	6.3	5.2	14.1	4.6	7.4	7.5	3.2	12.6	4.9	17.8	19.8	12.7	2.7	19.0	14.4	4.7	4.2	5.7	3.0	4.7	4.3	4.2	4.1	3.3	13.8	3.9	6.4	0.3	1.3	0.6	0.7	0.8	1.9	1.6	1.7	0.8	3.5	1.8	1.5	0.7	3.0	2.1	1.0	3.5	0.7	1.3	8.9	13.2	14.4	11.9	8.9	8.5	5.9	8.4	10.7	8.4
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526"	Supported		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB004526: AB_2128417, HPA002470: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	3.9	2.2	3.6	9.0	8.4	5.1	5.0	7.4	5.3	7.8	1.1	2.6	13.4	2.1	9.4	1.1	5.4	1.6	4.5	12.2	5.1	11.8	6.2	0.4	4.2	1.8	15.3	3.6	2.9	4.6	3.0	5.0	7.5	19.0	7.5	1.8	3.8	3.5	0.9	3.9	5.1	4.1	2.8	7.2	8.0	1.1	2.4	2.8	4.5	17.0	4.7	8.0	4.8	9.0	3.6	3.3	5.7	7.3	15.1	3.2	8.2	7.8	18.9	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.6	12.1	15.8	11.0	6.0	10.4	6.0	8.5	8.0	12.1	10.6	8.9	3.6	5.6	5.7	7.8	14.6	14.9	7.7	19.4	5.6	11.9	3.2	10.5	6.3	8.9	5.5	7.2	6.8	10.9	12.1	10.0	8.8	7.9	0.8	9.4	5.5	6.0	4.8	9.6	6.4	8.8	5.3	1.8	10.8	10.2	5.9	10.6	11.2	2.9	6.5	5.0	3.6	8.1	11.4	5.2	5.9	12.5	1.3	1.9	2.4	8.0	3.2	7.6	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favourable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.7	5.5	12.8	8.4	21.4	27.9	6.7	7.6	14.3	7.9	8.7	4.0	8.9	8.8	4.4	18.0	6.3	7.9	9.4	12.8	6.6	5.0	9.7	10.0	7.6	11.1	9.1	5.4	16.0	11.3	9.4	13.0	16.7	6.3	10.7	16.1	5.6	7.8	7.1	4.2	6.1	4.5	17.8	2.2	13.8	12.7	7.5	6.7	4.8	5.5	10.7	6.0	7.5	22.3	9.8	9.7	8.0	7.7	10.4	6.7	6.4	10.4	8.0	7.1	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74491712-74493733	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040249	Approved		Approved	Vesicles,Centrosome				Vesicles	Centrosome	"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	2.0	4.1	2.6	2.6	3.0	2.1	5.8	2.3	4.3	3.1	4.0	3.4	6.5	5.8	3.4	6.5	3.6	5.8	8.8	2.9	3.3	2.6	8.1	5.3	4.0	8.4	3.5	1.0	6.2	10.8	6.2	4.3	8.3	2.9	4.6	3.6	3.8	5.9	6.9	11.3	2.4	6.3	3.1	2.9	4.2	5.6	19.0	0.8	8.7	6.4	5.5	4.3	4.6	3.8	11.2	7.2	6.6	4.9	8.1	14.8	5.4	2.5	3.2	7.0	3.3	2.9	0.6	9.9	0.9	1.6	4.4	2.8	10.5	3.5	15.5	6.0	0.6	3.7	3.2	2.4	1.7	3.6	3.2	4.5	2.8	2.8	3.3	5.2	6.2	1.6	2.6	2.2	2.9	0.3	3.5	4.4	1.3	4.0	6.9	7.9	6.2	4.2	5.6	7.7	4.3	2.9	8.7	7.1	4.5	6.5	2.0	9.4	6.3	3.9	1.2	1.0	2.6	1.5	2.3	7.3	6.5	10.5	0.8	3.0	3.4	0.0	4.9	6.6	5.9	3.0	8.8	11.2	7.9	7.2	5.3	11.0	14.8	11.2	1.1	8.1	3.7	7.2	3.7	5.4	2.6	3.0	2.3	4.3	3.3	2.6	3.5	1.0	2.9	0.8
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA038640: "				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.5	2.3	3.1	5.4	1.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.9	0.1	0.9	0.8	1.9	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.6	0.5	0.4	0.2	0.2	0.2	6.6	0.1	6.7	0.2	0.4	3.8	0.3	1.5	0.3	0.2	0.9	23.5	0.2	0.8	1.3	1.6	0.3	1.5	2.5	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	44	"testis: 9.0"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 36.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA055743: , HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAL		ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"esophagus: 447.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 44.8;MOLT-4: 62.7;RPTEC TERT1: 227.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1"	"Lineage enriched"	"Detected in many"	44	"T-cells: 57.9"	"Low region specificity"	"Detected in all"							HPA065691			Approved	"Golgi apparatus,Centrosome"				"Golgi apparatus"	Centrosome	"HPA065691: "	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favourable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	2.3	2.0	14.3	3.5	21.8	3.7	2.0	1.8	20.6	35.8	3.7	43.2	0.4	2.0	1.8	3.4	447.4	3.4	2.2	3.3	18.2	8.3	53.1	1.7	4.3	5.9	27.4	13.2	2.0	1.9	1.6	0.2	2.2	11.8	2.5	2.9	2.8	42.5	3.9	2.0	3.7	2.4	2.1	27.6	3.2	9.3	1.7	27.2	35.0	5.8	56.1	90.1	2.6	64.8	0.6	0.2	0.4	0.1	1.3	57.9	13.7	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	0.0	22.2	227.3	5.7	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.6	42.0	7.5	0.0	0.5	57.9	26.4	0.4	1.3	0.0	0.2	40.1	13.7	14.3	21.8	1.8	20.6	18.2	8.3	27.4	13.2	11.8	27.2
MAPKAPK2		ENSG00000162889	"Mitogen-activated protein kinase-activated protein kinase 2"	P49137	1	206684944-206734283	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 18.7"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010297, HPA045556, HPA063708, HPA064435"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB010297: AB_2250405, HPA045556: , HPA063708: , HPA064435: "	"unprognostic (7.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (4.58e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.29e-2)"	23.0	25.3	11.6	21.2	15.7	58.6	23.9	11.1	14.5	19.3	25.6	17.2	14.5	25.7	20.0	18.5	23.5	17.3	26.0	89.2	12.3	8.7	33.7	26.7	26.7	21.5	16.7	6.5	23.3	19.1	16.9	22.8	13.6	15.7	20.2	14.4	17.8	19.8	14.4	62.9	18.3	32.9	18.3	14.6	37.7	23.1	21.3	14.6	26.9	24.3	25.2	28.2	22.9	46.1	1.1	18.7	3.2	1.1	2.3	1.6	0.5	20.9	8.3	11.5	12.9	34.0	20.0	14.3	14.6	33.1	22.3	21.1	15.8	10.2	10.1	10.2	29.4	15.9	8.6	15.5	16.1	11.7	6.5	16.9	10.3	10.2	26.3	24.9	56.6	27.5	19.9	21.4	23.7	18.2	19.4	45.9	18.0	26.0	10.0	18.0	13.3	11.6	25.8	24.1	3.2	16.8	12.8	9.2	11.9	17.2	29.1	20.2	14.1	24.2	17.3	20.1	17.0	23.3	19.8	59.8	53.1	8.2	22.8	15.2	6.6	1.1	0.7	1.4	1.6	1.1	1.5	1.0	1.2	1.5	0.6	1.1	0.6	1.1	3.2	2.3	1.0	18.7	1.4	0.5	11.6	15.7	11.1	14.5	12.3	8.7	16.7	6.5	15.7	14.6
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol			63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: "	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.0	36.1	48.8	31.9	69.4	51.4	50.6	34.7	51.3	52.9	53.7	42.7	39.1	55.5	20.6	45.4	38.8	54.9	64.3	75.9	33.6	42.4	52.1	33.8	67.8	38.1	59.9	41.3	50.9	43.9	49.5	29.3	40.3	28.8	40.4	69.5	26.5	52.4	60.5	28.6	45.0	41.9	57.5	54.4	87.5	41.8	45.3	27.0	29.1	46.9	66.5	34.2	62.5	23.4	40.6	39.8	33.7	43.6	50.4	44.2	67.9	50.1	54.2	33.5	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA040411, HPA041594"	Uncertain		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favourable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	7.0	6.7	11.5	11.9	11.4	15.4	10.0	8.2	12.7	11.9	28.7	9.6	12.4	5.1	15.2	12.7	5.4	20.3	6.5	6.7	12.3	10.0	8.8	4.9	6.8	12.8	11.4	10.5	10.9	11.3	8.8	22.8	6.0	14.9	12.3	11.1	9.0	6.8	15.9	3.8	4.2	9.0	18.8	11.4	9.5	9.8	20.7	12.4	14.6	11.0	5.3	13.4	17.0	8.9	7.1	4.0	13.3	17.2	6.0	8.1	5.4	4.9	4.1	8.0	7.7	4.0	5.4	6.1	6.6	3.7	10.6	9.8	4.9	2.3	11.4	4.4	3.0	5.1	5.4	3.5	12.1	14.9	5.2	25.0	5.3	3.4	6.1	13.8	9.9	2.4	4.6	7.1	6.9	5.9	4.7	12.8	6.1	3.6	19.5	9.8	4.2	5.1	19.2	7.1	3.3	5.0	4.3	7.3	3.9	6.4	3.8	6.5	9.2	10.0	3.1	8.5	3.7	5.3	6.0	6.7	19.5	7.7	4.5	9.0	5.4	6.0	4.7	13.3	5.0	11.1	8.1	6.8	6.4	5.2	4.0	7.1	7.7	6.2	3.1	6.0	17.2	2.3	5.9	5.4	11.5	11.4	8.2	12.7	12.3	10.0	11.4	10.5	14.9	12.4
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	11.8	22.1	12.4	12.1	14.2	7.0	14.2	17.0	15.4	15.3	14.0	16.4	17.4	13.1	16.1	17.8	17.0	13.2	9.9	15.3	12.7	9.5	17.5	14.7	10.4	11.4	14.8	9.3	12.8	17.6	14.5	23.5	17.4	13.8	16.3	15.4	13.2	15.3	14.0	23.0	12.1	15.4	15.3	9.6	13.3	12.9	14.6	11.5	20.9	15.5	13.1	16.4	16.0	12.9	15.0	20.0	13.6	22.1	11.6	10.8	11.5	14.8	12.6	13.6	16.2	12.9	14.2	16.8	9.5	9.1	13.5	10.8	16.0	10.2	20.2	18.8	11.1	11.3	23.2	12.7	17.1	11.6	7.4	18.1	9.7	14.1	12.3	15.4	11.5	11.1	20.0	12.9	19.3	16.7	24.5	9.7	16.1	13.3	17.1	11.0	17.7	10.2	23.8	16.4	7.3	19.3	9.6	12.6	10.0	13.5	6.4	12.7	12.9	16.1	16.3	9.6	20.8	5.8	11.7	10.1	13.5	42.7	5.3	17.1	13.5	13.0	19.6	13.6	8.7	22.1	10.8	14.2	5.8	9.8	20.0	15.0	7.9	9.3	7.3	11.6	14.8	17.8	10.2	11.5	12.4	14.2	17.0	15.4	12.7	9.5	14.8	9.3	13.8	11.5
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824802	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	23.7	32.9	23.8	25.4	25.0	12.5	24.3	35.5	29.2	22.5	19.5	17.7	20.0	15.9	25.2	27.2	28.0	21.2	16.8	21.9	24.6	21.2	28.1	20.0	16.8	26.7	21.5	30.9	29.2	20.0	38.5	33.0	25.2	24.0	26.3	20.7	15.5	21.9	21.8	33.3	24.4	19.3	21.5	26.7	23.9	21.0	21.7	27.3	33.9	28.2	19.2	34.1	24.1	28.2	21.2	20.3	34.3	21.5	29.6	26.0	15.1	15.2	15.9	27.7	18.2	23.6	14.9	17.1	24.7	17.2	20.1	23.5	24.7	10.0	16.4	23.6	15.2	27.8	24.6	20.1	23.8	27.7	14.8	39.8	28.7	18.5	18.5	23.6	21.3	13.8	22.1	19.1	17.4	19.6	35.9	14.1	23.9	11.4	19.2	17.9	19.5	13.9	28.2	27.8	10.5	20.8	22.9	17.6	17.3	21.7	18.6	10.0	28.0	15.2	18.5	20.4	14.5	22.4	19.9	17.4	41.9	35.9	17.2	22.6	14.9	21.4	15.8	34.3	23.4	21.5	22.9	21.2	23.4	22.0	20.3	18.6	24.1	23.5	14.4	29.6	17.1	16.7	26.0	15.1	23.8	25.0	35.5	29.2	24.6	21.2	21.5	30.9	24.0	27.3
MTMR9	"C8orf9, DKFZp434K171, LIP-STYX, MTMR8"	ENSG00000104643	"Myotubularin related protein 9"	Q96QG7	8	11284416-11328146	"Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070944			Approved	"Actin filaments,Centrosome"				Centrosome	"Actin filaments"	"HPA070944: "	"unprognostic (1.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.43e-2)"	8.2	7.0	11.5	7.5	14.0	8.0	9.2	18.2	26.2	6.6	9.9	10.3	2.7	4.4	8.3	5.7	6.4	5.6	5.9	12.9	11.6	14.4	8.2	5.7	6.6	6.9	11.7	12.2	6.9	7.2	9.4	8.4	7.8	13.1	9.3	6.3	6.4	4.8	7.6	9.1	6.9	5.2	11.1	10.8	6.6	5.3	16.8	7.4	8.2	7.1	3.7	7.4	6.4	5.6	4.5	4.1	3.6	3.9	2.3	3.7	1.2	2.6	7.3	6.6	5.2	8.1	6.9	5.1	8.2	5.4	6.6	6.1	6.5	2.0	6.7	2.2	9.8	3.7	7.2	7.2	7.6	1.4	4.4	8.9	5.8	3.3	8.8	2.3	5.2	6.8	5.8	9.5	12.0	10.3	6.0	5.4	10.7	2.0	4.0	2.4	11.7	4.4	2.9	10.7	2.1	7.2	6.7	2.5	10.0	5.5	2.4	5.8	3.0	4.7	12.8	7.9	5.8	4.4	4.3	1.5	3.0	3.8	6.5	5.1	7.6	1.5	3.2	3.6	3.2	3.9	2.8	3.5	2.7	2.7	2.8	4.5	3.2	3.7	3.1	2.3	3.2	4.1	2.0	1.2	11.5	14.0	18.2	23.2	11.6	14.4	11.7	12.2	13.1	7.4
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.9	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.1	0.0	0.0	10.9	23.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MZT2A	"FAM128A, MOZART2A"	ENSG00000173272	"Mitotic spindle organizing protein 2A"	Q6P582	2	131464900-131492743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.9"	"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"prognostic favourable (3.04e-4)"	"unprognostic (3.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.04e-11)"	"unprognostic (1.51e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-1)"	17.7	17.1	34.7	22.1	22.6	31.3	17.1	9.6	25.1	17.5	20.3	7.6	23.0	30.0	11.9	22.3	23.5	14.0	17.5	57.5	28.0	20.7	14.4	15.9	7.5	15.6	18.9	16.4	20.8	55.4	5.6	7.2	5.3	8.8	16.4	3.4	9.3	48.5	19.7	40.7	12.6	22.8	17.3	12.0	15.5	24.0	11.1	5.5	28.3	17.8	23.8	17.0	16.2	12.8	11.9	5.4	31.9	1.0	2.6	9.3	2.2	35.6	19.2	0.4	7.4	0.5	1.3	7.7	12.1	2.8	4.7	4.6	47.2	12.3	23.1	15.7	0.5	16.1	1.2	8.1	0.1	9.1	58.8	9.5	21.6	55.8	2.9	16.6	3.6	3.7	4.4	3.0	1.4	3.8	18.7	24.4	1.1	32.2	23.0	70.0	12.5	44.1	19.6	6.7	51.7	2.9	16.5	28.0	3.5	12.3	8.4	22.0	13.1	30.0	10.6	12.3	29.8	5.2	11.8	22.8	16.9	18.6	17.2	10.8	7.3	6.9	1.0	31.9	3.8	0.6	4.2	11.9	8.5	4.9	3.4	6.2	9.3	4.5	0.4	2.6	0.3	5.4	8.4	2.2	34.7	22.6	9.6	23.1	28.0	20.7	18.9	16.4	8.8	5.5
MZT2B	"FAM128B, FLJ14346, MOZART2B"	ENSG00000152082	"Mitotic spindle organizing protein 2B"	Q6NZ67	2	130181737-130190729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA051758, HPA052623"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA051758: , HPA052623: "	"unprognostic (8.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (9.37e-8)"	"unprognostic (1.67e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.09e-1)"	28.9	39.1	50.8	23.9	33.5	63.4	23.8	19.5	35.1	24.3	31.3	14.4	27.7	34.2	24.7	24.0	30.6	19.4	26.7	56.6	33.7	29.3	22.5	31.1	14.4	27.8	32.8	33.3	31.0	104.2	10.9	17.1	16.2	19.7	28.4	11.6	18.6	63.6	24.9	87.5	20.9	32.1	31.8	21.7	26.8	33.8	26.1	15.4	35.3	36.0	27.1	22.2	24.4	34.9	15.3	21.7	31.7	9.3	12.1	13.3	4.9	40.8	17.3	4.4	21.0	1.7	6.4	20.4	19.6	7.3	7.6	5.5	35.3	21.3	22.5	30.6	4.4	23.2	2.3	6.4	1.2	33.3	53.5	12.1	25.3	38.5	7.5	16.0	12.1	6.9	9.1	5.1	2.5	8.3	16.0	33.7	5.4	47.4	35.8	93.1	14.0	31.7	41.8	11.0	70.6	4.5	13.5	30.5	37.2	11.8	21.4	31.8	25.3	47.3	14.8	21.9	35.5	17.5	18.5	41.1	25.6	27.7	33.0	23.7	15.8	0.1	9.3	31.7	7.7	9.1	6.2	15.3	11.3	10.7	11.2	14.8	13.3	10.7	4.6	12.1	8.4	21.7	8.7	4.9	50.8	33.5	19.5	35.1	33.7	29.3	32.8	33.3	19.7	15.4
N4BP3	LZTS4	ENSG00000145911	"NEDD4 binding protein 3"	O15049	5	178113443-178126087	"Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;MCF7: 10.6;RH-30: 10.7;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4"	"Group enriched"	"Detected in many"	18	"B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030972, HPA030973, HPA061387"	Approved		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: "	"unprognostic (1.84e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.88e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.55e-2)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4.0	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2.0	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2.0	4.7	11.2	4.9	3.8	4.0	4.4	0.0	0.0	0.2	2.6	0.5	0.0	0.0	1.2	0.9	0.1	0.0	7.9	0.0	0.0	0.0	0.0	1.6	0.5	0.7	1.0	0.0	2.4	0.2	0.0	0.0	1.2	0.4	2.0	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	6.3	1.3	0.5	0.0	10.6	0.1	0.1	5.9	0.0	5.9	10.7	2.7	0.6	1.2	0.9	0.4	0.3	37.9	2.5	1.4	0.0	1.2	0.0	0.9	0.0	0.0	1.7	1.1	6.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	4.0	0.2	0.2	0.0	4.0	0.9	2.6	0.0	0.2	0.0	4.4	0.0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3
N6AMT1	"C21orf127, HEMK2, MTQ2, N6AMT, PRED28"	ENSG00000156239	"N-6 adenine-specific DNA methyltransferase 1"	Q9Y5N5	21	28872191-28885371	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034133, CAB034135, HPA059242"	Approved		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: "	"unprognostic (2.20e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.51e-3)"	5.4	10.9	10.1	6.0	18.6	2.0	10.5	7.4	14.8	9.9	7.0	17.0	6.0	6.7	13.8	13.7	5.6	9.3	6.2	10.8	10.8	9.2	9.0	6.3	5.5	6.7	21.3	8.4	18.3	6.6	14.6	15.6	13.1	14.1	10.1	7.4	8.4	6.5	9.0	11.3	8.0	6.2	7.8	14.5	7.9	6.7	7.6	19.3	3.9	12.1	4.0	6.9	8.7	9.2	2.2	2.0	1.6	2.1	4.1	4.8	1.8	3.4	3.0	7.7	10.7	6.4	7.1	5.9	7.4	3.0	4.3	2.6	3.8	6.1	3.8	3.7	4.0	4.0	6.6	3.7	5.4	4.8	5.0	8.0	4.7	4.7	5.8	4.8	3.1	3.6	8.0	4.4	3.0	3.2	9.8	6.7	8.9	3.4	2.2	3.8	9.7	4.3	3.4	7.3	2.8	8.0	5.0	5.9	8.3	6.7	2.4	2.7	3.3	4.2	7.4	3.7	6.5	6.6	4.4	4.1	4.6	2.1	5.7	12.5	6.8	1.1	1.5	1.6	1.8	2.1	2.0	2.2	3.4	2.3	2.0	2.2	4.8	3.4	0.5	4.1	1.6	1.7	1.4	1.8	10.1	18.6	7.4	14.8	10.8	9.2	21.3	8.4	14.1	19.3
NDC80	"HEC, HEC1, hsNDC80, KNTC2, TID3"	ENSG00000080986	"NDC80, kinetochore complex component"	O14777	18	2571511-2616635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 51.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066330			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA066330: "	"unprognostic (1.96e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (2.53e-8)"	"unprognostic (1.16e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-3)"	"unprognostic (7.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.69e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.71e-1)"	2.9	1.3	0.8	15.3	0.8	14.6	0.9	0.7	0.9	2.9	3.8	0.8	0.6	2.7	4.2	3.8	8.3	1.3	1.8	2.7	0.6	0.4	1.6	1.4	2.9	10.1	0.6	0.8	1.2	0.8	0.0	0.6	6.0	1.1	4.3	5.1	0.8	1.9	7.6	0.6	4.0	4.8	2.2	0.6	7.9	3.0	15.9	0.6	51.3	0.9	8.1	9.9	2.2	6.7	7.9	1.6	9.3	0.7	2.2	11.5	1.4	21.5	4.9	24.5	10.8	1.3	2.9	12.6	25.4	13.6	33.3	28.4	13.4	12.3	23.6	11.5	9.8	13.4	27.3	11.0	35.3	8.8	6.9	18.6	14.0	10.3	0.4	35.6	15.7	1.5	1.0	19.1	13.6	15.1	15.1	30.1	29.0	9.7	17.3	15.5	12.6	7.2	19.2	25.0	18.9	8.7	10.5	19.8	8.9	23.2	6.1	9.2	10.3	14.2	9.2	21.7	48.4	17.1	33.4	13.2	20.8	31.7	9.6	16.5	18.3	3.7	0.7	2.8	2.2	0.6	2.0	7.9	3.7	4.3	0.3	5.7	2.4	2.4	9.3	2.2	0.5	1.6	11.5	1.4	0.8	0.8	0.7	0.9	0.6	0.4	0.6	0.8	1.1	0.6
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: "	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (9.47e-6)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.3	21.9	16.8	12.0	1.0	1.7	18.5	11.7	11.0	20.7	17.8	11.7	29.8	16.1	5.7	9.0	16.3	14.5	8.8	26.1	24.6	12.1	7.7	19.1	15.7	0.1	15.2	10.5	0.5	1.0	15.9	17.2	13.2	21.1	28.4	20.7	8.4	16.5	10.3	15.9	11.2	16.4	25.7	24.5	7.2	8.7	15.2	16.9	16.9	19.0	14.7	29.2	9.1	6.9	10.3	20.5	20.3	31.4	11.8	21.7	21.3	9.0	11.7	17.1	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036999	Approved		Supported	Centrosome,Cytosol			960000	Cytosol	Centrosome	"HPA036999: AB_10672105"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.1	8.9	12.1	6.2	4.1	6.0	9.7	9.2	8.4	11.2	9.9	6.2	5.8	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.8	4.7	4.9	7.6	16.7	5.1	8.5	6.1	3.3	8.0	11.8	9.4	3.1	4.3	4.4	15.0	3.5	4.2	9.7	16.0	6.2	6.9	3.2	5.6	9.6	6.1	7.1	4.4	4.4	6.1	2.5	2.9	3.5	4.9	5.4	8.5	9.6	7.9	7.6	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3
NUDT17	FLJ34433	ENSG00000186364	"Nudix hydrolase 17"	P0C025	1	145845629-145848953	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 18.4;granulocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030145	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA030145: AB_10603883"	"unprognostic (8.93e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.63e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.07e-3)"	"unprognostic (6.55e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (5.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.96e-1)"	4.6	3.3	8.3	3.9	13.5	6.7	4.9	8.9	10.9	3.8	3.4	5.1	1.5	1.2	4.6	3.1	3.5	7.0	4.4	8.4	6.6	7.7	3.8	2.6	3.4	9.0	5.9	8.1	6.8	6.2	6.2	4.7	2.2	5.4	4.2	2.9	8.0	6.3	5.8	6.7	4.3	3.3	11.1	5.5	6.0	3.3	7.1	2.2	3.5	5.7	3.4	7.7	4.1	3.2	0.9	18.4	11.5	1.8	0.2	1.1	0.7	4.3	3.1	2.9	1.6	1.6	2.5	3.0	2.1	3.4	2.2	3.0	1.9	3.2	6.3	2.3	3.5	0.8	2.1	1.2	1.5	0.7	3.7	2.4	2.5	2.9	4.7	2.0	8.2	2.6	2.0	1.5	2.4	4.3	5.3	5.9	3.9	6.9	2.1	3.7	2.4	0.3	5.5	1.2	2.0	3.4	1.0	1.4	3.3	1.3	2.6	3.5	14.8	8.8	2.6	2.6	1.7	1.3	0.8	5.2	2.4	1.6	2.4	2.7	1.9	5.8	0.6	11.5	0.6	1.8	0.4	0.9	0.5	0.3	0.6	0.6	1.1	0.8	0.1	0.2	1.1	18.4	0.5	0.7	8.3	13.5	8.9	10.9	6.6	7.7	5.9	8.1	5.4	2.2
PAOX	PAO	ENSG00000148832	"Polyamine oxidase"	Q6QHF9	10	133379234-133391694	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Cell line enhanced"	"Detected in many"		"A-431: 6.2;U-266/70: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047782			Uncertain	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA047782: "	"unprognostic (3.67e-3)"	"prognostic favourable (6.07e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-2)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.20e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (9.49e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.29e-3)"	6.7	4.1	4.3	5.8	6.7	1.5	4.7	6.8	8.7	3.7	6.0	10.8	5.6	5.6	3.7	1.8	7.4	3.4	2.4	2.5	5.7	2.7	8.9	9.2	2.8	5.2	10.0	3.4	3.6	3.2	1.9	2.5	2.1	4.2	4.8	1.5	2.8	9.9	5.1	3.5	4.4	8.5	2.8	4.7	8.2	7.5	36.7	7.6	0.7	2.4	2.1	5.4	4.6	4.2	4.3	1.1	1.0	1.0	1.7	0.3	0.4	6.2	0.0	0.2	1.2	0.0	0.7	1.6	2.8	1.2	1.4	0.2	1.1	0.1	0.0	0.9	0.6	3.5	0.4	0.8	0.6	4.1	0.5	0.5	0.0	0.2	1.7	0.0	1.0	0.1	0.3	0.9	0.4	0.1	4.9	0.3	0.0	0.1	0.0	0.1	1.2	3.0	4.6	0.0	0.0	0.1	0.0	0.3	2.2	0.9	0.1	0.0	1.3	0.0	2.7	0.3	1.4	1.2	0.0	18.1	3.3	1.7	0.0	0.0	0.1	1.0	0.3	0.0	0.2	1.0	0.0	1.6	0.3	0.2	1.1	4.3	0.0	0.0	0.0	1.7	0.9	0.8	0.0	0.4	4.3	6.7	6.8	6.5	5.7	2.7	10.0	3.4	4.2	7.6
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 16.5;brain: 47.0"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive B-cell: 16.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome			1300000	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	4.5	3.2	18.4	1.1	24.7	4.1	1.5	6.7	47.0	1.8	1.3	7.8	0.0	0.9	1.0	2.1	1.0	1.1	2.4	5.7	15.0	10.0	3.5	2.3	2.3	1.4	21.4	11.0	1.4	2.0	0.7	1.3	0.7	16.6	2.5	1.3	0.0	1.0	5.6	2.0	0.9	1.0	1.2	11.0	1.6	1.7	1.6	18.9	0.7	1.8	0.0	1.4	1.1	0.6	16.5	1.0	2.5	0.0	0.7	0.1	0.2	0.0	9.3	12.4	0.0	3.3	2.6	0.0	1.8	0.1	1.3	0.5	0.0	0.0	2.7	0.0	1.4	0.0	1.0	0.3	0.6	0.0	4.9	0.1	0.1	0.0	3.2	0.3	0.1	6.1	0.3	1.5	2.5	1.0	0.3	0.1	20.3	0.7	5.6	0.0	0.1	1.2	8.5	0.4	0.0	0.2	0.0	1.6	0.6	0.0	0.1	0.1	0.0	0.0	23.6	0.7	0.6	2.9	0.9	3.6	0.0	31.0	5.3	0.0	2.4	2.5	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	16.5	0.1	0.1	0.1	0.7	0.0	1.0	0.0	0.2	18.4	24.7	6.7	24.6	15.0	10.0	21.4	11.0	16.6	18.9
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Supported	"Intermediate filaments,Centrosome"			7000	Centrosome	"Intermediate filaments"	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	12.1	7.0	5.6	15.8	28.2	14.9	8.3	8.7	18.8	12.3	14.6	27.4	12.7	4.2	4.8	9.1	10.0	8.5	16.2	7.1	1.2	6.9	9.2	9.6	62.6	30.2	9.2	7.7	12.2	9.4	11.1	8.6	11.3	17.0	8.8	9.1	10.3	10.9	11.4	4.5	7.5	7.2	6.0	15.0	14.7	23.0	7.2	6.6	6.6	36.4	8.5	10.1	21.9	7.6	9.1	6.0	6.8	7.2	5.7	2.4	4.1	9.4	12.4	8.9	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: "	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.6	3.1	3.0	2.0	2.5	2.5	2.7	4.2	2.6	2.4	5.6	1.5	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	2.2	4.6	5.0	4.1	1.4	3.8	5.5	1.0	2.7	5.6	3.5	2.1	2.6	4.3	3.7	3.4	1.6	3.6	1.1	3.5	3.6	2.6	6.1	3.5	3.2	2.1	5.9	3.8	2.3	5.4	5.3	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"				"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: "	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	55.6	0.1	0.0	0.1	0.1	17.6	9.7	0.1	0.1	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	0.3	0.0	0.0	0.1	0.0	18.7	0.1	0.0	0.4	8.3	0.1	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome				Centrosome	Vesicles	"HPA037583: AB_10671762"	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.3	0.2	9.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	4.3	0.1	1.4	16.9	0.1	0.2	0.1	1.4	0.1	5.8	0.0	0.0	0.3	0.1	0.0	0.3	3.4	0.1	0.0	0.0	0.0	2.0	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA017327: , HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome			8200000	"Nucleoplasm, Centrosome"		"HPA049518: , HPA061796: "	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.85e-4)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.1	47.1	33.7	31.9	45.4	39.2	33.3	31.6	37.6	55.8	47.4	39.6	35.2	27.5	29.5	42.9	30.2	53.8	39.4	53.9	16.8	37.2	17.4	34.4	139.6	35.9	21.1	21.0	43.7	37.0	41.3	34.5	57.6	26.2	15.6	45.6	65.1	12.0	29.0	37.4	76.4	16.2	25.4	18.3	43.3	32.1	43.0	33.5	22.2	45.2	30.3	21.8	27.5	30.9	27.3	27.8	25.2	31.0	13.5	26.8	20.6	21.3	17.1	33.8	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome				Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.1	6.4	8.8	12.7	5.7	7.2	12.4	7.0	7.2	9.4	9.4	7.4	5.1	20.5	6.4	7.8	10.9	13.1	8.5	11.9	9.7	10.0	10.0	6.8	7.6	9.0	22.5	9.0	7.0	13.3	10.0	14.8	6.6	18.0	6.7	7.7	6.9	7.2	11.0	9.2	7.5	19.7	11.3	5.2	10.2	7.1	7.7	7.9	5.6	13.1	10.3	8.6	17.5	6.5	6.7	5.5	7.1	10.8	3.9	5.5	12.0	9.1	15.3	9.9	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7
RABL2A		ENSG00000144134	"RAB, member of RAS oncogene family like 2A"	Q9UBK7	2	113627229-113643396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome				Centrosome	Vesicles	"HPA042642: , HPA042700: , HPA044007: "	"unprognostic (7.76e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.77e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.78e-3)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.19e-5)"	2.2	1.7	6.0	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9.0	2.7	29.3	2.8	3.3	7.0	6.0	3.5	3.4	12.9	1.8	4.0	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2.0	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2.0	5.5	2.0	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.5	4.3	5.9	4.7	4.9	7.2	4.5	2.4	2.0	3.4	2.5	3.7	1.6	3.6	10.3	0.8	2.7	3.0	0.3	2.3	5.0	5.7	1.8	0.1	0.5	4.0	0.7	1.3	2.5	5.1	0.7	1.5	2.5	1.7	0.9	2.1	2.1	12.0	0.9	3.3	1.5	2.2	2.3	1.6	2.4	0.6	2.4	8.3	2.3	2.5	2.1	0.5	3.4	0.6	0.4	0.8	0.9	1.6	3.6	3.7	0.8	7.0	2.7	1.2	0.0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8.0	8.6	6.8	0.5	12.2	7.2	9.8	5.0	5.5	6.0	9.5	6.3	20.9	7.0	6.0	4.0	7.5	6.4	4.3
RABL2B		ENSG00000079974	"RAB, member of RAS oncogene family like 2B"	Q9UNT1	22	50767501-50783663	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome				Centrosome	Vesicles	"HPA042642: , HPA042700: , HPA044007: "	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.86e-3)"	"prognostic favourable (5.58e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (4.58e-5)"	"unprognostic (3.14e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.37e-3)"	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13.0	8.4	12.7	12.6	7.9	13.9	59.0	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7.0	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10.0	11.0	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.4	12.3	21.0	16.4	23.6	18.8	15.4	10.1	11.3	8.2	11.3	3.4	11.9	8.7	9.0	14.5	17.7	9.6	11.8	8.9	7.5	13.6	7.5	21.1	8.9	9.8	21.1	8.1	16.0	16.2	10.8	13.6	9.1	5.7	11.0	16.3	17.0	10.5	9.3	8.0	9.2	17.8	12.1	9.1	15.9	13.4	9.0	16.4	12.4	11.0	7.6	10.8	6.6	14.0	7.9	15.8	6.7	6.8	9.3	4.3	4.2	14.9	5.3	11.0	1.0	10.9	9.2	16.8	17.4	12.2	11.2	13.0	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13.0	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.0	25.3	18.1	21.2	7.4	8.4	47.7	17.3	11.1	16.8	12.3	28.2	20.2	27.0	10.9	13.4	41.7	20.2	15.2	5.8	28.0	26.0	16.5	31.6	32.9	13.4	30.5	21.2	9.3	15.8	10.4	11.6	17.4	35.8	13.2	11.5	38.0	32.6	21.1	34.0	21.8	42.7	21.7	26.3	11.1	16.9	59.8	24.8	30.5	35.9	21.3	30.8	30.8	21.1	21.8	19.0	22.9	27.9	11.3	12.9	21.9	18.3	14.9	20.3	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2
RAPGEF6	"PDZ-GEF2, PDZGEF2, RA-GEF-2"	ENSG00000158987	"Rap guanine nucleotide exchange factor 6"	Q8TEU7	5	131423921-131635236	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA037982, HPA037983"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA037982: AB_10670535, HPA037983: "	"unprognostic (1.86e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.72e-3)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.81e-4)"	7.2	7.3	8.4	15.2	11.2	15.7	9.9	34.1	12.7	7.2	6.7	13.7	6.1	5.0	6.9	5.9	6.5	6.1	7.7	6.6	9.4	10.5	6.2	8.4	9.5	24.6	13.1	9.0	8.6	6.2	12.5	9.5	8.0	17.1	7.2	7.8	5.4	6.9	7.9	6.9	8.1	7.3	6.9	10.9	11.3	6.5	19.7	14.5	21.2	7.1	5.5	22.0	7.7	7.2	5.4	1.6	8.7	2.0	5.3	14.2	5.4	6.9	5.0	7.1	6.6	3.7	4.2	6.8	7.7	6.1	6.6	10.0	9.1	4.9	16.2	5.2	5.1	5.6	9.9	8.0	13.4	7.9	5.4	10.2	7.3	4.9	3.0	7.1	10.8	3.1	3.8	9.6	9.3	5.8	5.8	9.8	5.8	3.5	7.3	5.7	3.1	3.8	10.9	10.2	8.6	4.8	5.5	24.5	5.6	8.0	3.6	9.5	5.1	6.2	5.7	8.7	6.2	7.0	8.8	5.7	6.8	17.7	5.0	9.4	7.4	1.4	1.7	6.3	6.3	2.0	10.7	4.5	8.5	6.8	1.4	5.4	14.2	10.1	8.7	5.3	1.5	1.6	9.6	5.4	8.4	11.2	34.1	12.7	9.4	10.5	13.1	9.0	17.1	14.5
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 43.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	43.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8										
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
RHEBL1	"FLJ25797, MGC34869, RHEB2"	ENSG00000167550	"RHEB like 1"	Q8TAI7	12	49064685-49070025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;brain: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.3;U-266/84: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053111, HPA061001"	Uncertain		Uncertain	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA053111: , HPA061001: "	"unprognostic (2.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.81e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.03e-5)"	"unprognostic (9.13e-2)"	"unprognostic (9.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-10)"	"unprognostic (4.67e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.07e-1)"	1.6	0.6	3.6	2.7	2.0	4.0	2.3	4.0	9.5	0.8	1.1	0.4	1.3	1.1	3.3	2.5	0.9	5.5	1.0	1.4	2.2	2.7	0.9	0.7	2.6	6.8	2.0	5.1	1.0	0.6	0.2	0.7	1.4	1.9	0.5	1.8	0.4	1.0	1.3	0.6	5.6	1.8	1.0	1.2	5.2	1.2	3.0	0.9	2.5	0.8	0.0	3.9	1.0	4.1	3.1	0.9	10.6	1.6	1.3	10.1	1.2	0.9	1.9	1.2	2.8	0.7	0.1	1.1	0.9	2.7	5.0	5.6	1.8	1.6	2.8	0.8	0.2	0.7	0.8	1.0	2.2	16.3	0.1	2.7	1.4	0.9	0.6	1.0	5.7	0.3	0.4	2.5	0.8	1.9	3.4	7.9	1.9	0.8	1.2	6.6	1.8	2.8	2.6	1.7	4.3	0.4	0.1	0.6	1.7	0.7	0.7	4.4	0.3	1.8	1.0	1.5	2.6	3.0	0.9	9.6	32.6	1.6	1.3	4.0	0.6	10.6	0.3	0.7	7.3	1.6	10.1	1.9	3.1	3.9	0.7	3.1	1.0	3.8	0.6	1.3	1.4	0.9	6.1	1.2	3.6	2.0	4.0	9.5	2.2	2.7	2.0	5.1	1.9	0.9
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"				Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favourable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	20.4	20.1	19.0	19.5	18.4	12.2	16.9	10.8	13.3	13.8	22.5	13.9	7.7	16.3	11.6	13.3	21.1	12.4	14.2	44.3	17.6	16.7	35.0	32.5	21.0	23.6	22.2	10.7	11.6	13.0	14.5	15.6	12.7	19.1	12.6	17.2	13.6	12.2	18.9	45.2	18.5	29.0	17.7	23.1	19.2	16.9	14.4	15.3	25.6	29.3	27.1	18.0	14.3	11.2	17.8	22.1	38.6	27.9	15.5	18.0	12.6	21.3	9.3	10.9	6.2	21.5	35.3	13.3	15.7	14.2	12.5	12.3	11.0	13.7	25.6	13.4	13.0	20.9	13.9	15.7	15.0	21.7	10.9	13.4	11.0	27.5	11.5	6.0	0.3	19.1	14.9	16.7	25.9	28.1	14.1	14.1	19.8	19.3	21.3	2.8	5.5	23.4	12.2	15.3	26.3	14.8	13.5	5.1	11.5	13.0	51.9	22.1	29.2	11.3	15.2	14.0	22.7	17.7	9.4	18.3	15.1	19.9	18.3	9.7	18.9	5.6	17.1	38.6	12.3	21.6	14.3	17.8	12.8	14.4	19.5	12.3	10.6	13.7	6.8	15.5	27.9	22.1	18.0	12.6	19.0	18.4	10.8	12.5	17.6	16.7	22.2	10.7	19.1	15.3
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364636-89412270	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.8;SCLC-21H: 14.5;U-266/70: 35.2;U-266/84: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;monocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA068664: "	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	8.1	8.4	9.2	2.6	12.8	8.9	8.8	22.4	16.3	8.7	3.3	7.9	3.1	2.2	2.1	6.6	12.8	11.9	3.7	29.9	8.6	7.4	21.8	5.0	6.4	2.8	8.5	7.9	2.2	6.4	16.0	11.5	3.4	10.7	5.9	2.4	12.8	38.7	4.2	60.0	5.5	2.1	7.5	12.6	4.4	2.3	6.1	9.2	4.1	23.3	13.9	5.2	9.2	9.3	0.1	0.7	6.3	3.9	0.1	0.6	0.3	0.0	0.7	1.9	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	10.5	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.8	7.0	8.3	0.1	0.6	0.0	0.0	0.0	0.2	27.8	0.0	0.7	3.3	3.5	1.5	0.7	7.0	10.1	0.1	2.5	0.2	14.5	0.8	0.2	0.9	11.8	0.3	5.6	0.0	0.8	1.2	5.0	1.3	35.2	16.3	0.0	2.7	5.3	0.8	3.9	1.2	2.6	0.0	1.1	0.1	0.1	0.4	0.0	0.7	0.0	0.3	0.6	6.3	0.1	3.9	0.6	0.0	0.3	9.2	12.8	22.4	9.1	8.6	7.4	8.5	7.9	10.7	9.2
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol			13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: "	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.6	5.0	9.1	8.9	14.1	17.4	6.4	19.5	25.0	17.6	18.3	4.9	10.7	7.6	12.1	22.4	8.4	37.0	18.4	31.0	6.3	3.8	13.4	7.4	5.6	15.1	12.2	13.7	14.7	27.2	20.3	23.7	10.3	8.5	8.6	17.6	6.4	14.0	10.1	3.8	7.2	8.0	17.7	4.8	15.4	14.0	6.0	7.7	7.9	6.0	8.3	7.5	8.7	13.0	19.3	18.3	12.2	19.9	11.7	12.1	6.5	15.1	14.0	13.8	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 89.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Supported	Vesicles,Centrosome				Vesicles	Centrosome	"HPA073224: "	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.2	89.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638600-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 18.8;pituitary gland: 10.7"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 14.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA066648: "	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.6	3.2	5.2	0.7	6.6	2.7	0.6	18.8	18.7	0.6	0.7	0.4	0.0	0.6	0.7	0.6	0.7	0.7	0.8	0.9	10.9	10.7	2.9	0.7	0.6	0.6	5.7	7.5	0.7	1.8	0.6	10.7	0.6	11.7	0.7	0.8	0.2	0.6	0.6	0.6	0.7	0.7	0.6	4.6	0.7	0.8	0.7	1.4	0.0	0.7	0.0	0.6	0.6	0.0	2.9	4.1	3.0	2.3	0.2	4.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.0	0.0	0.0	3.0	1.9	1.9	3.7	1.3	3.6	2.9	2.3	2.1	0.9	2.9	3.0	4.3	2.1	0.2	2.3	4.1	2.9	0.3	5.2	6.6	18.8	9.7	10.9	10.7	5.7	7.5	11.7	1.4
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 21.3;SH-SY5Y: 13.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	1.2	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.1	0.2	21.3	13.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958618-86963260	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 93.7;RT4: 77.2"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 292.8"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581"	Enhanced	Supported	Supported	"Nuclear bodies,Centrosome"				Centrosome	"Nuclear bodies"	"CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (2.29e-8)"	"prognostic unfavourable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	74.1	78.3	82.3	5.3	20.8	1.0	28.9	12.3	44.5	9.5	5.8	4.6	6.4	4.8	6.1	12.0	11.0	26.5	6.2	9.0	40.0	92.9	4.1	1.9	4.6	4.9	72.9	35.1	15.0	3.5	1.6	1.7	4.9	100.1	11.9	2.7	10.8	10.9	44.4	6.6	8.5	5.4	5.8	35.2	20.2	2.6	2.9	5.3	0.2	3.4	3.3	9.6	76.6	18.3	0.0	0.7	0.0	2.4	0.0	1.8	0.6	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	93.7	0.0	1.9	0.1	7.8	0.0	0.3	0.0	0.0	0.0	0.5	18.2	0.3	0.1	0.0	0.1	0.4	7.3	0.0	0.0	6.6	0.6	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	77.2	0.0	0.0	0.6	1.0	0.1	20.3	0.0	17.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.6	82.3	20.8	12.3	44.5	40.0	92.9	72.9	35.1	100.1	5.3
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 126.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;HMC-1: 26.0;SK-MEL-30: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.6;eosinophil: 2.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, HPA043084"	Enhanced		Supported	"Focal adhesion sites,Centrosome"				"Focal adhesion sites"	Centrosome	"HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favourable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	95.0	6.4	23.0	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45.0	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42.0	20.0	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40.0	5.5	19.3	0.0	4.0	12.7	1.2	63.9	31.4	0.1	0.0	7.6	1.2	0.6	1.0	0.2	0.7	0.6	6.3	1.6	2.3	0.1	0.9	0.2	0.0	0.2	0.0	14.9	5.6	0.0	1.2	0.1	0.3	1.1	0.2	0.1	1.7	2.3	3.6	0.2	8.9	0.8	0.0	26.0	0.4	0.2	0.3	0.1	2.6	5.9	1.2	0.6	0.4	0.0	0.3	2.9	1.4	0.5	2.1	0.2	7.0	9.8	2.7	2.0	0.9	0.3	22.3	1.2	0.2	0.2	0.0	2.2	0.1	1.2	0.8	0.2	0.1	2.7	0.2	6.3	7.6	0.2	2.2	0.7	1.2	1.0	0.1	0.3	0.4	0.0	0.1	0.3	0.1	0.2	0.6	0.2	0.0	0.5	0.2	23.0	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA052245: , HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	27.7	11.7	0.0	2.4	3.2	6.3	10.6	0.0	0.0	0.0	1.3	14.1	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	19.9	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.1	1.2	0.1	0.0	14.9	0.2	1.5	0.7	0.3	0.0	0.8	0.0	0.3	0.0	0.3	0.0	3.4	2.1	14.0	0.1	0.2	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4
TCEA2	TFIIS	ENSG00000171703	"Transcription elongation factor A2"	Q15560	20	64049836-64072347	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043836	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA043836: "	"unprognostic (6.51e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.91e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.65e-3)"	"unprognostic (9.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.79e-1)"	14.8	19.5	31.4	7.9	32.8	6.6	9.3	34.7	40.4	18.3	11.7	17.7	11.0	5.6	18.8	10.9	8.4	24.5	13.5	19.1	27.7	30.0	14.8	27.5	10.9	9.2	27.2	32.8	30.3	16.1	18.6	17.9	14.7	26.5	16.9	3.2	14.5	17.9	22.3	30.7	10.4	7.8	11.7	18.3	16.2	10.5	32.0	18.9	8.7	15.0	6.1	5.2	10.9	15.4	9.7	3.0	4.4	2.6	3.6	5.5	1.6	7.5	8.2	13.1	22.2	11.7	7.3	5.3	7.9	8.8	14.0	6.7	4.8	13.4	8.6	17.8	9.1	20.2	5.2	6.7	2.7	5.3	10.3	3.2	14.3	12.6	17.4	3.6	4.6	11.3	6.0	3.6	4.6	9.5	5.6	16.2	4.2	16.5	14.7	17.5	8.4	19.8	14.3	9.9	22.2	7.0	5.0	12.9	21.8	8.0	5.5	19.8	15.0	9.0	13.5	25.2	13.3	14.2	4.8	18.9	12.4	4.6	22.4	4.2	5.0	2.4	1.7	4.4	3.6	1.6	1.6	9.7	3.2	2.6	2.1	5.0	5.5	3.4	0.8	3.6	2.6	3.0	5.4	1.6	31.4	32.8	34.7	37.6	27.7	30.0	27.2	32.8	26.5	18.9
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	3.6	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	8.0	6.4	7.4	14.0	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053786: , HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	6.9	1.7	20.0	22.6	2.9	2.7	7.3	4.0	4.6	9.6	7.2	10.2	8.9	18.7	10.6	3.9	7.2	16.2	10.4	9.4	8.8	5.9	23.4	4.0	13.5	4.6	9.9	5.7	4.2	6.9	2.0	7.4	9.4	11.2	11.5	4.6	9.9	16.8	18.9	16.7	5.0	14.4	23.9	10.2	6.3	4.6	6.0	17.8	1.2	10.6	10.0	12.7	22.1	6.8	1.5	6.3	0.1	7.5	13.2	4.9	17.6	0.1	11.9	7.5	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8
THAP6	MGC30052	ENSG00000174796	"THAP domain containing 6"	Q8TBB0	4	75513946-75550473	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035767	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Nucleoplasm	"HPA035767: AB_10696510"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-2)"	15.7	14.9	11.5	18.7	17.6	14.4	18.6	21.2	17.0	18.4	17.0	24.4	16.5	14.9	20.2	23.8	15.5	15.6	13.5	17.2	12.0	11.9	17.8	21.9	13.1	17.9	21.9	14.0	19.3	14.9	19.9	30.9	24.3	17.8	18.3	14.5	17.3	17.0	13.3	20.3	20.8	21.1	18.8	19.2	17.8	13.1	26.5	21.3	18.0	20.4	16.9	15.2	16.5	14.3	10.7	7.1	18.5	8.7	6.8	13.6	6.5	6.8	4.9	10.9	7.6	12.4	12.3	6.2	16.4	8.4	8.6	8.9	6.2	17.1	10.0	8.4	5.3	7.3	9.8	7.8	10.5	11.3	6.8	7.2	8.0	7.9	17.2	9.7	8.2	10.3	13.6	9.8	15.1	4.6	12.4	20.5	9.0	8.0	8.7	6.6	6.2	5.1	8.5	12.0	6.8	8.0	5.8	8.4	8.6	7.7	10.5	9.1	11.4	8.1	5.6	14.7	9.7	16.9	8.4	18.4	9.0	9.4	10.2	7.8	12.3	14.6	8.7	12.2	9.8	7.5	13.0	8.9	11.9	9.2	7.1	10.7	13.6	10.4	18.5	6.8	8.0	5.9	13.0	6.5	11.5	17.6	21.2	16.5	12.0	11.9	21.9	14.0	17.8	21.3
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol			110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome				Centrosome	Midbody	"HPA057689: "	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.4	0.7	1.3	1.8	6.3	2.2	4.7	1.2	1.1	1.7	0.9	1.0	0.6	0.9	11.1	8.8	2.5	5.9	1.2	3.9	3.7	0.8	1.7	2.1	1.3	0.5	6.0	3.5	0.8	2.4	6.4	10.0	0.9	2.4	5.9	2.8	12.5	1.1	5.1	2.1	3.9	1.8	0.8	4.9	2.2	8.3	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;SK-BR-3: 17.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077996			Approved	Nucleoli,Centrosome				Centrosome	Nucleoli	"HPA077996: "	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	15.9	14.6	2.7	12.2	2.9	1.4	7.3	0.9	3.4	9.3	7.9	6.0	8.5	6.6	15.7	10.6	8.7	7.8	5.6	4.1	3.6	2.2	7.1	4.4	7.9	11.7	2.6	3.9	11.4	5.5	4.5	5.5	8.7	4.7	9.5	6.8	7.8	10.2	6.3	2.0	6.2	14.2	5.8	6.2	16.6	6.1	4.6	4.3	12.5	7.0	5.0	14.3	10.0	7.8	12.8	15.9	15.2	15.9	5.9	9.5	7.8	2.2	1.3	0.5	0.2	5.2	8.1	16.2	3.4	10.0	8.9	8.7	1.0	7.9	8.0	1.6	4.6	3.7	0.3	7.4	4.5	10.4	0.3	4.2	0.4	0.4	2.3	4.6	3.0	8.5	6.4	4.5	1.4	11.5	0.2	0.6	4.2	1.0	4.2	2.7	0.0	0.7	6.2	0.3	0.5	5.4	6.1	0.0	0.0	0.1	17.3	2.5	3.0	2.2	9.2	2.3	0.5	0.9	1.2	0.9	1.0	3.1	6.7	0.6	1.1	8.7	14.3	3.6	5.6	15.9	6.1	12.6	5.4	6.9	15.9	12.8	6.8	5.7	15.2	5.9	13.5	8.1	9.5	7.8	2.7	2.9	0.9	3.4	3.6	2.2	2.6	3.9	4.7	4.3
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell line enriched"	"Detected in some"	7	"A549: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA077996			Uncertain	Nucleoli,Centrosome				Centrosome	Nucleoli	"HPA077996: "																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	9.9	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0
TTC30A	"FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612992-177618966	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA051714: , HPA052100: , HPA052487: "	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.7	4.1	3.8	1.5	7.1	0.4	5.6	2.2	7.1	4.2	3.4	5.9	7.8	2.2	5.0	10.9	2.4	8.4	4.8	4.4	3.7	4.2	6.9	4.6	3.7	1.4	3.6	6.6	5.5	4.4	11.6	8.1	1.9	4.8	3.9	3.3	5.0	8.1	4.0	3.5	1.9	2.5	3.6	3.0	1.7	3.6	24.5	2.1	2.6	9.6	4.6	1.7	3.1	1.7	0.5	1.6	1.9	1.6	0.2	2.7	1.0	5.7	3.3	3.3	0.0	6.8	5.6	2.4	2.8	8.1	5.0	5.3	1.0	4.2	1.3	5.5	4.9	4.8	2.2	6.2	5.5	0.4	1.8	1.1	1.6	1.4	2.7	1.4	1.3	3.4	4.1	2.8	1.1	2.3	0.8	0.5	3.5	2.9	4.4	2.6	1.8	1.2	2.9	8.8	0.6	6.3	1.5	10.9	7.2	2.5	5.0	3.0	2.8	1.4	2.1	3.1	1.9	3.4	2.3	2.3	2.1	0.4	7.8	0.1	3.0	0.0	1.3	1.9	0.4	1.6	0.1	0.4	0.1	0.4	1.6	0.5	2.7	1.2	0.7	0.2	1.3	0.6	1.0	1.0	3.8	7.1	2.2	7.1	3.7	4.2	3.6	6.6	4.8	2.1
TTC30B	"fleer, FLJ30990, IFT70B"	ENSG00000196659	"Tetratricopeptide repeat domain 30B"	Q8N4P2	2	177548998-177553014	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA051714: , HPA052100: , HPA052487: "	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.65e-1)"	2.4	4.6	4.4	1.9	4.9	0.7	10.5	3.2	5.1	4.8	4.0	7.7	3.8	3.1	4.9	8.9	3.7	13.2	4.5	2.3	3.9	3.8	10.8	4.3	5.5	2.5	3.1	1.5	6.0	5.2	8.0	7.0	3.3	3.4	3.5	3.7	4.5	4.4	4.2	1.2	3.0	3.7	3.1	5.2	3.1	4.7	11.5	2.9	7.7	10.4	1.6	2.8	3.3	2.2	3.2	3.9	6.5	3.4	1.9	2.2	1.6	2.8	4.2	5.7	1.1	5.1	5.9	3.8	1.7	5.3	4.7	5.0	2.4	7.1	1.1	4.7	3.2	7.0	6.8	7.2	4.5	1.6	3.4	2.0	2.7	2.1	4.2	2.5	3.5	4.9	6.8	4.6	3.5	3.7	2.6	1.0	2.7	4.8	5.0	3.9	2.6	1.1	3.9	4.9	1.1	7.0	3.1	13.8	7.8	2.1	4.9	3.3	5.0	4.8	3.2	2.6	1.4	3.3	1.5	2.6	2.9	0.3	5.9	1.0	4.3	6.5	3.4	2.8	1.7	3.3	1.1	1.4	1.2	1.8	3.9	3.2	2.2	2.2	2.0	1.9	2.2	2.8	1.0	1.6	4.4	4.9	3.2	5.1	3.9	3.8	3.1	1.5	3.4	2.9
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.2	25.4	9.4	9.5	10.0	10.9	12.0	14.3	23.3	17.7	17.9	26.4	12.8	13.8	8.1	16.3	12.3	12.5	11.7	7.8	12.9	24.0	8.8	12.5	14.5	12.6	18.8	16.3	11.3	10.3	16.4	20.4	11.6	10.7	11.2	14.2	25.0	10.3	20.9	8.2	20.2	8.2	10.9	6.0	11.6	9.5	6.4	12.7	10.2	11.5	11.5	8.3	9.7	14.0	8.6	7.8	11.3	12.7	11.2	7.6	16.1	34.7	8.5	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4
TUBGCP5	"GCP5, KIAA1899"	ENSG00000275835	"Tubulin gamma complex associated protein 5"	Q96RT8	15	22983192-23039673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039366, HPA040366"	Supported		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA039366: AB_10673243, HPA040366: "	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.53e-3)"	5.1	5.7	5.7	5.1	8.4	5.5	7.3	4.0	10.4	7.9	4.6	6.0	4.6	4.2	7.4	8.7	5.9	4.9	4.7	6.6	7.7		6.3	6.8	5.6	5.5	6.0	11.0	5.0	10.0	10.2	6.3	4.8	12.9	7.5	5.3	5.3	4.0	7.4	14.5	7.3	3.0	9.3	10.0	4.8	5.3	12.9	5.9	5.4	8.6	7.0	6.1	4.6	0.8	5.3	4.0	1.5	3.3	5.4	7.6	2.5	12.1	12.9	15.3	9.0	11.8	7.7	8.8	15.2	16.8	16.8	14.6	9.8	5.8	9.2	6.5	13.9	12.3	10.0	11.8	14.1	14.2	4.0	16.6	13.0	5.2	3.9	16.9	7.4	12.6	4.5	11.2	10.4	10.0	11.7	15.0	10.6	8.0	11.3	7.3	9.0	11.8	14.0	16.8	1.8	9.7	19.0	5.2	8.9	12.4	8.7	7.9	14.1	7.9	8.6	11.6	7.6	8.9	22.5	11.8	11.8	24.9	15.2	11.2	10.8	0.2	2.3	0.9	4.5	3.3	4.6	3.7	6.7	7.2	3.6	5.3	6.0	7.6	1.5	5.4	3.3	4.0	5.4	2.5										
TWSG1	TSG	ENSG00000128791	"Twisted gastrulation BMP signaling modulator 1"	Q9GZX9	18	9334767-9402420	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014898	Uncertain		Supported	Centrosome,Cytosol	"Secreted - unknown location"		6600000	"Centrosome, Cytosol"		"HPA014898: AB_1858467"	"unprognostic (2.55e-1)"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	13.0	8.9	8.3	6.9	8.5	2.9	17.3	5.0	6.2	21.9	17.4	9.3	56.2	4.7	33.0	21.5	19.0	14.4	16.4	9.2	8.4	7.1	19.8	4.8	12.6	6.6	11.0	6.1	20.4	4.4	12.7	11.4	10.7	9.1	26.5	10.2	10.6	9.4	34.8	6.1	7.6	8.6	36.0	12.3	9.4	12.0	13.0	8.1	4.3	20.5	8.7	6.8	26.0	17.9	3.3	7.8	7.5	4.1	4.1	7.5	3.1	14.8	5.4	15.6	7.7	30.8	27.9	7.2	28.4	35.4	15.6	22.5	5.7	19.6	2.1	14.4	37.5	5.2	15.2	11.2	28.9	5.8	4.3	3.8	4.6	2.8	27.4	2.7	8.0	28.2	9.2	13.1	6.3	24.2	5.8	3.9	40.0	4.5	3.0	3.4	5.1	4.4	5.3	16.0	1.3	17.7	19.9	2.0	5.4	22.3	6.2	6.0	7.0	6.5	20.0	28.7	14.4	26.9	17.7	5.8	5.1	4.0	17.6	3.9	10.1	7.5	4.1	5.8	6.7	2.2	4.4	3.3	3.2	6.8	7.8	2.8	3.8	7.5	2.0	4.1	0.7	7.8	1.4	3.1	8.3	8.5	5.0	6.2	8.4	7.1	11.0	6.1	9.1	8.1
UBE2Q1	"NICE-5, PRO3094, UBE2Q"	ENSG00000160714	"Ubiquitin conjugating enzyme E2 Q1"	Q7Z7E8	1	154548577-154559028	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063368	Approved		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA063368: "	"unprognostic (3.88e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.64e-3)"	"unprognostic (5.32e-3)"	"unprognostic (6.10e-3)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.84e-7)"	"unprognostic (2.20e-1)"	"unprognostic (4.46e-1)"	"prognostic favourable (1.86e-5)"	"unprognostic (1.04e-2)"	17.3	18.7	26.5	16.2	29.4	24.2	19.4	26.4	29.0	20.0	21.2	18.7	8.2	16.2	18.3	25.4	20.9	21.8	18.2	17.6	24.5	25.8	25.7	27.4	23.0	26.3	22.8	21.0	21.7	27.2	21.4	29.3	24.5	27.2	21.4	25.7	18.5	19.0	19.8	19.1	21.6	21.4	21.9	19.1	26.0	20.5	30.0	22.0	25.1	21.0	14.0	29.9	19.3	18.5	3.2	5.1	8.1	3.1	4.7	6.2	1.6	18.0	15.7	22.2	16.9	22.8	23.6	19.2	17.9	27.4	23.2	18.8	17.6	19.4	22.3	25.9	25.0	15.8	26.1	20.8	20.0	22.4	16.5	17.7	14.0	17.0	28.8	28.7	28.5	22.7	27.6	18.7	21.7	29.7	14.8	27.7	29.5	28.0	17.5	21.1	30.3	26.7	20.2	15.5	23.4	25.4	19.3	22.6	31.6	18.2	34.3	29.4	20.9	43.8	20.6	15.0	16.8	17.7	19.1	33.8	25.0	29.5	16.8	20.3	22.7	8.1	2.8	5.6	4.8	3.1	4.3	3.0	4.5	5.9	2.5	3.2	5.0	5.7	4.4	4.7	2.6	5.1	6.2	1.6	26.5	29.4	26.4	29.0	24.5	25.8	22.8	21.0	27.2	22.0
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA023932: "	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	8.8	8.0	4.2	5.5	12.7	9.0	4.0	7.1	7.2	5.5	6.3	4.7	8.4	11.9	2.1	9.5	7.9	6.7	5.9	7.9	8.9	4.8	13.3	7.9	5.9	7.7	4.4	14.3	9.7	8.8	5.9	10.8	5.9	8.9	11.6	8.0	4.3	9.5	7.6	7.9	5.6	6.1	6.5	6.0	7.9	7.0	2.4	4.7	5.5	8.4	6.1	8.6	7.3	11.8	7.2	5.4	6.3	4.7	10.3	5.0	12.8	7.2	6.4	5.4	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.9;breast: 24.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.3;CACO-2: 6.5;CAPAN-2: 9.7;EFO-21: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 6.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050101, HPA063569"	Uncertain		Approved	Centrosome,Cytosol	"Secreted to extracellular matrix"			Cytosol	Centrosome	"HPA050101: , HPA063569: "	"prognostic favourable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	25.9	14.1	0.8	1.6	1.0	0.9	24.1	1.8	0.9	3.4	7.6	1.4	0.7	2.6	1.9	6.0	4.7	3.1	3.4	7.2	0.4	0.4	1.2	8.5	4.8	2.3	0.5	0.1	4.3	7.8	0.5	2.3	6.3	2.2	4.0	1.2	1.0	3.4	1.3	11.1	4.5	7.9	3.1	0.3	3.5	0.7	3.7	0.5	0.3	10.8	5.4	0.7	4.6	10.2	0.0	0.0	0.8	0.1	6.6	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.1	20.3	0.0	0.0	0.0	0.1	6.5	9.7	0.0	32.2	0.0	3.0	0.6	0.0	0.0	2.9	1.1	1.6	0.7	1.2	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	1.6	0.2	0.0	1.2	0.1	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.8	1.0	1.8	0.9	0.4	0.4	0.5	0.1	2.2	0.5
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	18.9	17.7	12.5	10.8	23.2	14.8	25.8	24.3	25.9	22.8	19.4	8.6	16.0	16.1	21.6	17.9	19.9	20.8	14.4	14.8	12.7	15.8	19.6	26.6	16.2	13.8	14.8	16.2	35.8	35.1	16.0	31.1	12.6	27.4	23.7	18.7	10.3	23.3	18.1	16.9	13.5	20.2	23.7	16.5	17.5	20.3	10.3	13.2	19.0	42.6	16.1	17.0	26.7	21.3	18.5	20.0	6.4	13.9	17.2	25.1	16.8	19.3	6.2	8.6	7.6	11.9	24.0	8.7	11.6	15.7	10.2	13.4	6.8	15.4	19.1	13.8	8.8	13.2	10.0	16.7	15.4	16.0	10.0	10.9	10.5	8.0	21.9	13.3	7.3	19.5	40.2	7.1	69.7	12.7	16.4	27.4	10.5	12.7	16.5	9.6	2.5	19.6	11.3	7.4	8.5	12.8	18.0	8.8	5.7	8.3	5.3	19.0	17.6	9.9	8.1	7.6	11.1	10.8	16.1	10.9	6.7	11.7	9.0	1.2	5.8	6.4	13.9	3.9	11.3	10.2	19.4	18.5	18.5	15.0	20.0	13.4	25.1	18.7	1.4	17.2	11.8	11.6	21.1	16.8	12.5	23.2	24.3	25.9	12.7	15.8	14.8	16.2	27.4	13.2
ZNF12	"GIOT-3, KOX3, ZNF325"	ENSG00000164631	"Zinc finger protein 12"	P17014	7	6688433-6706923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA063402			Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA063402: "	"unprognostic (2.68e-1)"	"unprognostic (6.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.89e-3)"	"unprognostic (5.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.46e-3)"	16.7	12.1	12.1	15.6	11.7	8.8	17.0	25.4	13.5	18.9	17.7	9.2	16.0	12.2	17.4	17.9	15.1	15.1	11.9	12.6	10.1	9.7	15.6	13.8	12.2	15.1	10.3	12.8	19.6	13.2	25.2	20.0	20.3	10.3	23.9	13.2	8.6	14.7	16.1	9.5	13.8	18.6	12.5	16.1	18.6	12.9	7.5	13.9	21.1	21.9	7.9	16.0	21.9	29.3	2.1	1.9	9.4	0.9	1.9	3.5	0.4	12.6	6.0	12.0	15.0	12.3	12.5	11.5	8.0	14.5	10.3	10.8	8.1	7.4	9.6	5.6	9.9	15.2	9.9	7.8	15.7	3.6	7.5	9.7	9.0	8.1	11.5	15.3	10.5	13.7	17.4	7.4	11.9	7.4	15.3	8.9	13.5	10.0	5.9	14.2	14.5	9.3	7.8	17.2	5.8	8.4	12.6	11.0	19.5	9.2	16.8	9.6	10.7	17.5	7.3	11.6	14.7	9.2	10.5	8.5	5.5	9.9	9.5	10.4	15.3	9.4	0.9	1.1	2.5	0.7	3.5	2.0	2.1	2.8	0.9	2.1	2.7	3.4	0.9	1.9	0.8	1.9	1.7	0.4	12.1	11.7	25.4	13.5	10.1	9.7	10.3	12.8	10.3	13.9
ZNF274	"ZKSCAN19, ZSCAN51"	ENSG00000171606	"Zinc finger protein 274"	Q96GC6	19	58183029-58213562	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028880	Uncertain		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA028880: AB_10601929"	"unprognostic (2.38e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.58e-3)"	9.9	7.6	5.9	8.8	7.0	8.8	15.4	16.6	6.7	7.5	9.9	11.7	14.0	6.3	10.0	12.2	11.7	9.8	14.7	12.0	5.9	4.8	7.3	14.0	12.0	12.8	12.5	5.5	16.8	8.9	20.3	10.9	7.6	9.5	10.4	5.8	14.5	8.6	11.0	11.2	11.4	10.6	10.6	8.7	10.7	8.3	19.3	7.9	6.1	15.3	8.6	10.9	11.2	12.8	16.3	6.7	23.0	8.0	14.0	18.1	8.8	8.8	6.3	10.5	4.3	6.7	9.9	10.2	7.3	4.0	8.0	7.2	3.6	6.6	3.0	4.8	4.5	2.5	4.9	10.2	11.2	6.2	38.3	14.3	6.1	5.9	10.8	10.2	23.7	7.8	13.2	9.9	19.1	6.4	10.7	13.8	6.0	5.8	5.5	9.1	10.0	6.1	12.4	2.7	13.2	6.0	3.7	6.8	3.1	9.8	4.3	8.2	10.4	19.3	6.1	4.4	6.6	5.0	8.2	6.3	6.6	10.1	1.9	11.3	9.1	13.7	4.7	23.0	9.3	5.1	14.3	13.8	12.2	13.2	6.7	16.3	18.1	13.0	17.3	14.0	8.0	3.1	15.3	8.8	5.9	7.0	16.6	6.7	5.9	4.8	12.5	5.5	9.5	7.9
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076588	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.8;lymphoid tissue: 26.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.3;SK-BR-3: 11.0;U-698: 19.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA046940: , HPA049576: "	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"	1.4	0.8	2.4	22.8	3.4	10.5	7.3	6.6	1.4	3.0	7.1	0.4	3.2	6.4	1.0	1.2	11.3	1.4	4.0	1.4	2.0	1.7	1.4	1.0	3.4	15.9	1.1	0.1	0.6	2.7	0.3	3.5	0.7	0.8	2.4	1.0	0.8	13.8	3.4	0.8	6.2	10.1	0.6	1.3	16.9	5.5	2.6	0.6	4.3	1.7	9.5	26.2	2.0	2.7	29.8	26.7	14.7	6.2	14.7	3.5	2.6	3.0	2.1	0.0	0.4	0.0	0.2	1.7	0.5	0.0	0.2	0.2	3.4	1.2	16.3	1.9	0.1	5.7	0.8	1.3	0.0	3.4	4.3	4.8	0.9	3.3	0.9	2.7	5.1	0.7	0.6	0.7	0.0	0.4	3.4	5.8	0.0	4.6	0.2	4.5	1.9	4.3	9.1	0.0	9.8	0.4	1.1	3.1	0.3	2.0	11.0	0.1	2.4	5.4	1.1	0.0	1.7	0.1	0.0	6.0	6.0	19.1	0.1	3.4	0.1	14.7	3.6	5.7	3.0	6.2	3.5	29.8	1.6	3.3	8.8	22.4	0.7	1.7	1.8	14.7	5.8	26.7	1.4	2.6	2.4	3.4	6.6	1.4	2.0	1.7	1.1	0.1	0.8	0.6
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.5"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023106	Approved		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	7.3	5.9	4.3	8.3	4.2	9.3	13.0	7.3	7.4	7.0	13.9	1.3	2.9	12.3	5.7	4.6	9.7	6.2	9.4	5.3	4.3	6.3	2.3	6.8	7.3	9.9	4.8	14.3	4.4	9.1	9.9	7.5	6.6	8.9	3.4	7.6	7.4	6.2	3.9	7.5	3.9	8.1	10.5	7.0	5.7	40.5	8.7	6.7	10.1	5.2	5.0	8.2	6.6	17.4	14.5	10.1	2.8	10.3	15.4	4.1	0.2	0.2	11.8	0.4	4.0	6.2	2.1	7.7	5.9	8.0	7.2	0.0	0.5	0.1	5.8	6.7	0.7	0.0	6.0	2.3	0.2	4.2	0.3	0.5	0.2	10.0	0.1	7.9	10.7	0.0	7.6	0.1	3.5	0.1	0.5	5.3	0.2	6.4	0.2	20.3	2.7	0.1	0.0	0.2	2.3	3.1	0.2	11.2	0.2	2.9	0.2	0.4	0.3	2.2	12.6	0.3	0.2	5.0	0.3	0.1	0.2	0.2	0.3	0.1	10.1	2.2	6.4	5.1	2.8	7.3	9.6	7.2	5.6	6.1	17.4	15.4	10.0	2.6	10.3	1.8	14.5	4.5	4.1	5.9	8.3	13.0	7.0	5.3	4.3	9.9	4.8	6.6	8.7
ZNF747	MGC2474	ENSG00000169955	"Zinc finger protein 747"	Q9BV97	16	30530367-30535347	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003203, HPA069173"	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA003203: AB_1080753, HPA069173: "	"unprognostic (3.82e-2)"	"prognostic favourable (6.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.46e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.01e-1)"	12.5	10.5	11.0	8.9	12.4	5.7	10.3	13.1	19.4	14.1	11.3	18.5	6.3	9.6	14.3	10.3	8.9	11.8	10.5	13.2	10.3	8.9	11.4	17.0	8.4	9.3	11.5	8.0	13.2	15.5	23.1	10.4	6.2	10.6	14.6	9.2	13.6	11.2	15.3	14.1	11.0	10.5	11.8	9.4	11.4	10.2	12.4	13.3	18.2	11.8	6.7	9.0	12.8	8.8	8.8	8.1	9.0	4.8	6.6	8.9	4.1	3.8	3.7	1.2	6.1	4.9	4.3	6.2	3.2	4.8	4.6	4.5	2.2	4.9	8.3	2.2	3.8	5.7	2.8	4.0	2.0	9.8	6.2	7.2	4.0	3.4	5.4	3.3	10.3	4.9	5.1	3.7	5.8	3.0	2.0	7.2	3.2	4.2	14.8	4.6	7.2	2.5	17.7	0.4	7.6	4.0	2.0	8.6	7.6	4.8	3.2	3.5	6.2	6.6	2.4	5.9	2.7	4.6	0.1	13.7	9.6	4.7	1.2	5.1	6.9	9.0	4.8	6.4	4.5	2.6	5.2	7.4	5.1	5.2	6.0	8.8	8.9	6.6	2.7	6.6	2.4	8.1	3.8	4.1	11.0	12.4	13.1	19.4	10.3	8.9	11.5	8.0	10.6	13.3
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favourable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.8	9.2	6.0	5.6	5.5	5.0	4.3	5.6	4.5	4.6	7.1	6.0	3.3	4.3	3.7	2.7	4.1	3.8	3.2	5.1	7.4	5.2	6.8	7.6	5.7	4.9	7.0	5.6	5.2	3.6	4.7	3.9	4.7	7.6	7.3	3.9	2.8	2.8	2.4	4.8	2.9	2.3	10.6	2.5	3.8	10.0	3.7	7.1	8.4	3.2	3.7	4.0	8.5	3.5	5.7	7.6	5.1	4.5	7.2	6.3	4.3	3.6	4.9	3.8	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	6.3	8.2	12.4	9.8	18.8	3.3	10.3	22.2	14.0	8.2	8.5	8.2	11.6	5.7	10.8	12.3	5.5	10.0	6.6	12.5	9.4	7.2	9.4	6.7	5.9	9.7	8.1	10.8	16.6	8.1	10.5	24.7	7.1	11.6	9.7	7.6	9.3	7.9	10.5	6.9	7.1	7.6	9.7	7.8	9.2	7.2	5.0	11.4	8.7	14.0	6.4	9.8	9.1	8.2	4.2	5.9	1.5	3.2	2.3	5.1	1.3	2.6	3.4	5.8	4.0	3.5	2.3	0.0	3.0	2.2	3.3	4.4	6.2	2.4	6.4	2.8	3.1	1.5	4.8	1.9	4.0	5.4	2.4	5.0	6.1	3.9	2.4	7.4	4.2	3.4	1.2	4.6	2.9	3.1	5.2	8.7	3.4	1.2	2.4	1.2	5.7	3.6	3.5	10.2	2.2	1.9	14.2	6.4	6.8	5.3	2.3	1.9	2.7	3.2	5.6	3.3	8.1	5.7	4.6	6.6	8.5	5.0	3.0	3.9	2.7	0.1	3.2	1.5	2.8	2.8	2.9	2.5	3.4	3.3	2.4	4.2	5.1	4.2	0.6	2.3	1.8	5.9	1.9	1.3	12.4	18.8	22.2	14.0	9.4	7.2	8.1	10.8	11.6	11.4